Florida Society Of Clinical Oncology

2018 FLASCO FALL SESSION November 9– 10, 2018

Orlando World Center Marriott Conference Agenda Key 2018 FLASCO Track 1 Multi-Disciplinary Track 2 Pharmacy Fall Session Track 3 Nursing/Patient Navigator Track 4 Administrator

Thursday, November 08, 2018 Diamond Elite Events Bristol-Myers Squibb Crystal A Teva Oncology Crystal B 7:00 – NON CME Merck Crystal C 8:30 pm EVENT AstraZeneca Crystal D Genentech Crystal E

Friday, November 09, 2018 Diamond Events Bayer Crystal A EMD Serono Crystal B 7:30 – NON CME Astellas Crystal C 9:00 am EVENT Boehringer Ingelheim Crystal D Pfizer Biosimilars Crystal E 9:10 – FLASCO Board Meeting Crystal G1 12:30 pm Diamond Elite Events Amgen Crystal A Pfizer Oncology Crystal B 12:45 – 2NON CME Celgene Crystal C 2:15 pm EVENT Alexion Crystal D Takeda Oncology Crystal E FLASCO Board Group 1: Platinum Corporate Members Crystal K 2:30 – NON CME FLASCO Board Group 2: Platinum Corporate Members Crystal L 3:50 pm EVENT FLASCO Board Group 3: Platinum Corporate Members Crystal M 4:00 – Poster Presentations Crystal Foyer 6:00 pm 6:00 – Cash Bar/Visit Exhibits Crystal H 7:30 pm Dinner & Program Crystal G Rick McDonough, MD, FLASCO President 7:30 – Conference Opening and Welcome

10:00 pm Keynote Speaker ~ Monica M. Bertagnolli, MD, ASCO President Caring for Every Patient, Learning from Every Patient CE Moderator: Luis Raez, MD, FACP, FCCP, FLASCO Vice President & Chairman of Disparities in Oncology Committee Saturday, November 10, 2018 7:00 – 8:00 am Registration/Breakfast/Visit Exhibitors Crystal H Opening Remarks & Supporter Recognition Edgardo Santos, MD, FACP, FLASCO Program Chairman Crystal G 8:00 – 9:30 am General Session ~ Precision Medicine CE Moderator: Eric Harris, DO, Florida Cancer Specialists and Research Institute Speaker: Howard McLeod, PharmD, Moffitt Cancer Center/University of South Florida 9:30 – 10:15 am Break/Visit Exhibitors Crystal H Multi-Disciplinary CE Pharmacy CE Nursing/Patient Navigator CE Administrator non-CE Crystal G Crystal D & E Crystal B & C Crystal F

Neoadjuvant Breast Cancer Moderator: Ray Bailey, RPh Beat the Cancer, Save Your Heart 10:15 – 11:45 am Florida Cancer Specialists Rx to Go Oral Oncolytics 10:15 – 11:00 am Moderator: Shannon Luker, BSN, Moderator: Zeina Nahleh, MD, FACP 10:15 – 11:00 am Difficult Conversations Cleveland Clinic Florida OCN, CBCN, CN-BN Mabel Arslanyan, BS, PharmD, BCOP Parrish Medical Center 10:15 – 11:45 am Pathology – Laila Khazai, MD Jessica Unzaga, PharmD, BCPS, Natalee Roper, RN,BSN,CHPN Moffitt Cancer Center Beth Sussman BCOP Moffitt Cancer Center Surgical – Stephanie A. Valente, DO, FACS Executive Coach Miami Cancer Institute, Baptist Cathy Elstner RN, BSN Cleveland Clinic Ohio Hospital of Miami Moffitt Cancer Center Panelists: Medical – Mohammad Jahanzeb, MD, Abby Castillo FACP, FASCO Navigating Patients: Sylvester Comprehensive Cancer Medical Marijuana Understanding Clinical Trials Moffitt MHCT at Memorial Center/University of Miami 11:00 am – 12:15 pm Gail Erentreich Radiation - Amber Orman, MD 11:00 – 11:45 am Cancer Care Centers of Brevard Florida Hospital/University of Central Victoria Robinson, PharmD, BCOP Moderator: Katie Goodman, RN, BSN, CCRP Florida Florida Cancer Specialists Emory University Hospital Josh Mattson Midtown Case Study – Sofia Palacio, MD Christin Hart, RN, BSN, OCN Mayo Clinic Florida Jackson Memorial Hospital/University Marcos Rejtman, DO, HMDC Florida Hospital Cancer Institute of Miami Fellowship Program Memorial Cancer Institute, Jose Ortiz-Pagan, Survivor Memorial Healthcare System Beth Davison, MSN, APRN, CNM The Leukemia & Lymphoma Society Lunch Buffet located in Crystal Foyer 11:45 – Choice of Networking Crystal G1 (NON-CE), Rare Disease Presentation Crystal A (NON-CE), or 12:45 pm Breast Cancer Presentation Crystal B & C (Lunch only CE for MD/DO/PA/NP through Rockpointe & CEU for Nurses through LLS) Multi-Disciplinary CE Pharmacy CE Nursing/Patient Navigator CE Administrator non-CE

CLL: New and Projected Moderator: Dina Dumercy McHenry, Supportive Care Throughout Breakthroughs PharmD, BCOP BCPS Miami Cancer Institute, Baptist the Cancer Journey Prior Authorizations 12:45 – 2:00 pm Hospital of Miami 12:45 – 2:25 pm 12:45pm-2:15pm Moderator : Asher Chanan-Khan, MBBS, MD Mayo Clinic Florida Revenue Integrity Moderator: Ana Rosa Espinosa, Moderator: Sarah Cevallos Florida Cancer Specialists Jan A. Burger, MD, PhD 1:00 – 1:55 pm DNP, MBA, RN, OCN Memorial Cancer Institute/Memorial MD Anderson Cancer Center, University Julia Khalil, PharmD, BCPS Panelists: Healthcare System of Texas Sylvester Comprehensive Cancer David Segal Moderator: Adrienne Vazquez Case Study – Sonikpreet Aulakh, MD Center/University of Miami Aetna Guerra, MSN, ACNP-BC, Mayo Clinic Florida Fellowship Program Jorge García, PharmD, MS, MHA, AOCNP Andrew Hertler, MD Case Study – Jeremy Ramdial, MD MBA, FACHE Sylvester Comprehensive Cancer New Century Health Jackson Memorial Hospital/University Miami Cancer Institute, Baptist Center/University of Miami of Miami Fellowship Program Hospital of Miami Maen Hussein, MD Palliative Care – Mayra Lima, Florida Cancer Specialists APRN, MSN, FNP-C Hereditary Genetics focusing on Amanda Brahim, PharmD Patient Assistance Best Sylvester Comprehensive Cancer Prostate Cancer Center/University of Miami Memorial Healthcare System Practices Pain Management – Ana Garcia, 2:05 – 3:30 pm Shelli Johnson Moderator: Edgardo Santos, MD, FACP 2:00 – 2:45 pm APRN, MSN, FNP Memorial Cancer Institute, Memorial Cancer Care Centers of Brevard Lynn Cancer Institute, Boca Raton Regional Sarah Francis, PharmD, BCOP Healthcare System Hospital/Florida Atlantic University Candice Banks Jackson Memorial Hospital Survivorship – Jessica McMillan, Cancer Warrior Medical – Louise Morrell, MD DNP, FNP, APRN-BC Lynn Cancer Institute, Boca Raton Regional Mayo Clinic Florida Medical – Jingsong Zhang, MD, PhD Shaping the Future of Patient Collections Moffitt Cancer Center Changes in Oncology Clinical Healthcare through Nursing Pathology – Jasreman Dhillon, MD Trials Landscape Moffitt Cancer Center 2:30 – 3:30 pm 2:25 – 3:00pm

Radiation – Tim Williams, MD 2:45 – 3:30 pm Moderator: Cheryl Habaue, MSN, South Florida Proton Therapy Institute RN, OCN, CCRP Shelli Johnson Anay Moscu, PharmD, BCPS, Cancer Care Centers of Brevard Case Study – Brittany Rogers, MD Andrea Uitti, DNP, RN BCOP Brandy Cunningham University of Florida Fellowship Program Moffitt Cancer Center Florida Cancer for Nursing & Florida Action Coalition Cancer Care Centers of Brevard 3:30 pm Adjourned

The FLASCO staff and membership appreciates the time and dedication the following members volunteered to plan and implement the FLASCO 2018 Fall Session. 2017-18 PROGRAM COMMITTEE

Edgardo S. Santos Castillero, MD, FACP Lynn Cancer Institute, Boca Raton Regional Hospital Program Committee Chair

Eric Harris, DO Joseph Rosenblatt, MD Florida Cancer Specialists University of Miami Co-Chairman Co-Chairman Seth Berkowitz, LCSW, CCLS The Leukemia and Lymphoma Society Rosa Caiseda-Acantilado, MSW Miami Cancer Institute Don Champlain, RN, MHA Florida Cancer Specialists Gail Erentreich Cancer Care Centers of Brevard Jorge Garcia, PharmD, MS, MHA, MBA Baptist Health South Florida Adrienne Vazquez Guerra, MSN, ACNP-BC, AOCNP University of Miami Cheryl Habaue, MSN, RN, OCN, CCRP Ardeshir Hakam, MD, MBA Moffitt Cancer Center Shannon Luker, RN, OCN, CBCN, CN-BN Parrish Medical Rick McDonough, MD Florida Medical Clinic Zeina Nahleh, MD, FACP Cleveland Clinic Florida Brendan Prendergast, MD Health First Cancer Institute Jose Sandoval-Sus, MD Moffitt Cancer Center Malignant Hematology & Cellular Therapy at Memorial Healthcare System Winston Tan, MD Mayo Clinic Florida Beau Toskich, MD Mayo Clinic Florida Teri Valls, CMP, CMM The Medical Educator Consortium Jonathan Zager, MD, FACS Moffitt Cancer Center The Florida Society of Clinical Oncology Welcomes you to…

The FLASCO Fall Session Friday, November 9, 2018

Rick McDonough, MD President, Florida Society of Clinical Oncology Florida Medical Clinic

BIOGRAPHY: Dr. Rick McDonough is from Clearwater and has lived most of his life in Florida. He is a proud graduate of the University of Florida. He enjoys traveling, reading and spending time with his wife and three children. Dr. McDonough is a long standing active member of the Florida Society of Clinical Oncology and has proudly served on the board of directors for the past five years. Dr. McDonough practices at Florida Medical Clinic, a large multi specialty group in the greater Tampa area. Dr. McDonough is active in medical mission work, traveling every year with a group to Guatemala, providing primary care to a rural area in the mountains northwest of Guatemala City since 2003.

Luis E. Raez, MD, FACP, FCCP~ Moderator FLASCO Vice President and Board of Directors Member Director, Memorial Cancer Institute, Memorial Healthcare System Clinical Professor of Medicine, Herbert Wertheim College of Medicine Florida International University

BIOGRAPHY: Luis E. Raez, MD, FACP, FCCP; is the Medical Director of Memorial Cancer Institute (MCI), he is also the Oncology Research Director of Memorial Healthcare System (MHS) and Director of the Thoracic Oncology Program, as well as the Clinical Professor of Medicine at Florida International University (FIU) and Visiting Professor of Medicine at Cayetano Heredia University in Peru. Currently Dr. Raez designs phase I-III clinical trials with new chemotherapeutic agents and combinations. Dr. Raez does translational research in the areas of cancer vaccines and has been funded by NCI and the pharma industry. Dr. Raez has given oral presentations and lectures in national and international meetings in the US, Europe, Latinamerica and Asia. He is American Board Certified in: Internal Medicine, Medical Oncology and Geriatric Medicine. He is board elegible in Hematology. Dr. Raez is a member of AACR, ESMO, ASCO, IASLC, ALLIANCE, NCCTG, ACCP, ACP, ACSG, FLASCO among other institutions.

~Caring for Every Patient, Learning from Every Patient~

OBJECTIVES: 1. Understand the purpose of ASCO as an international organization of physicians caring for patients with cancer 2. Be better informed concerning national and global challenges with areas of access of care and clinical cancer research 3. Become aware of resources that ASCO provides to its members to promote high quality clinical care, education, and research

Monica M. Bertagnolli, MD 2018 – 2019 ASCO President Chief, Division of Surgical Oncology and Associate Surgeon Brigham and Women’s Hospital, Dana-Farber Cancer Institute Richard E. Wilson Professor of Surgery in the Field of Surgical Oncology, Harvard Medical School

BIOGRAPHY: Monica M. Bertagnolli, MD, a long-time member and volunteer of ASCO, took office as President during the ASCO Annual Meeting in Chicago in June 2018. “Serving as ASCO President is a tremendous personal honor for anyone in the field of oncology,” said Dr. Bertagnolli. “Much more importantly, it is an opportunity for me to make a meaningful difference by providing a strong voice in the health-care community for those whom I consider to be my particular constituency: clinical and translational researchers, community and academic oncologists participating in clinical research, and surgical oncologists.” Dr. Bertagnolli has been an active ASCO member since 1995, Dr. Bertagnolli is Chief of the Division of Surgical Oncology at Dana-Farber/Brigham and Women’s Cancer Center, Professor of Surgery at Harvard Medical School, and an Associate Surgeon at Brigham and Women’s Hospital and Dana-Farber Cancer Institute. Dr. Bertagnolli has served on the ASCO Board of Directors; the Cancer Prevention Committee; and the Strategic Planning Committee, among others. Dr. Bertagnolli received her board certification in surgery in 1993. She went to the University of Utah School of Medicine and completed her residency in Brigham and Women’s Hospital in surgery. Dr. Bertagnolli has clinical interests in familial adenomatous polyposis, gastrointestinal cancers, gastrointestinal stromal tumors, and sarcoma.

2018 FLASCO Travel Award Recipients

Throughout the year FLASCO offers the opportunity for FLASCO member Oncology Focused Trainees to submit applications for Travel Awards. It is our sincere hope that FLASCO is providing a great service to FLASCO’s Associate and Affiliate Members. If you have suggestions on how we may better serve our membership, please do not hesitate to contact FLASCO. Best of ASCO- FL Hospital September 14-16, 2018 in Orlando, FL Leslie Maxwell, MBA- Florida Hospital BIOGRAPHY: Leslie Maxwell has over 30 years of experience in the health care field, with 18 of those being in oncology. She served as the 2001-2017 Administrator of Florida Hospital Cancer Institute Central Region and then joined Florida Hospital Waterman as the Cancer Institute Director in September 2017. Leslie is responsible for program operations and development, strategic planning, marketing, physician relations, financials.

2018 ASTRO Annual Meeting October 21-24, 2018 in San Antonio, TX David Asher, MD- University of Miami BIOGRAPHY: David Asher is a PGY-4 and current, co-chief resident in the Department of Radiation Oncology at the University of Miami and Jackson Health System. Raised in Elon, North Carolina, he graduated from Duke University with a B.A. in Religion. He then completed his medical degree at Virginia Commonwealth University where he was inducted into the Alpha Omega Alpha (A.O.A.) Honor Society. At the conclusion of transitional year internship at Riverside Regional Medical Center in Newport News, Virginia, he was voted the top intern by his upper level residents. In June 2016, he began his training in Radiation Oncology in Miami, Florida. He has a passion for serving his community and considers it a privilege to be an oncologist. He has interests in a variety of areas including MR-guided radiotherapy, brachytherapy, health disparities, and quality improvement. He currently resides in Miami Beach with his wife, Adelina, and his two kids, Henry (age 3), and Norah (age 1). Pharmacy Student Travel Award Yen Tran, MBA- Nova Southeastern University BIOGRAPHY: Yen Tran is PharmD candidate 2019 from Nova Southeastern University - College of Pharmacy. He received his Bachelor of Pharmacy degree from the University of Medicine and Pharmacy of Ho Chi Minh city in Vietnam and Master of Business Administration from Solvay School of Business- Belgium. He has 10-year working experience in pharmaceutical industry and commercial management for multinational corporations such as Merck, AstraZeneca, Abbott and Les Laboratories Servier, across therapeutic areas including cardiovascular, diabetes, oncology and respiratory. He was awarded Best Product Marketing Manager by Merck Vietnam in 2015. He is a member of Rho Chi Honor Society, Phi Lamda Sigma - Pharmacy Leadership Society, Dean’s Ambassador and Kappa Psi Pharmaceutical Fraternity, Inc. Upon graduation from Doctor of Pharmacy program, Yen Tran aims to pursue a PGY-1 pharmacy practice residency program and PGY-2 in oncology specialty. Alyssa Donadio, PharmD- Baptist Hospital of Miami BIOGRAPHY: Alyssa Donadio, PharmD, is currently a PGY-2 Oncology Pharmacy Resident at Baptist Hospital of Miami, where she also completed her PGY-1 Pharmacy Practice Residency. Before moving to Florida, she obtained her Bachelor’s Degree in Biology from Cornell University in 2013 and her Doctorate of Pharmacy from Albany College of Pharmacy and Health Sciences in 2017. In addition to FLASCO, Alyssa is also involved in the American Society of Health System Pharmacists (ASHP) as well as the Florida Society of Health System Pharmacists (FSHP). Her areas of interest in oncology include hematologic malignancies and investigational drug services.

ASH Annual Meeting December 1-4, 2018 in San Diego, CA

Bilal Farooqi, MD- University of Florida BIOGRAPHY: Bilal Farooqi, MD is a third year fellow in hematology-oncology at the University of Florida in Gainesville. He completed his residency in internal medicine from Mercer University in Macon, Georgia and was excited to move back to Florida to complete his fellowship here. Dr. Farooqui is looking forward to graduating from fellowship in June 2019. He plans to reside in his hometown of Tampa, FL and looks forward to being more involved in the community as a hematologist-oncologist following the completion fellowship.

Monica Chatwal, MD- Moffitt Cancer Center BIOGRAPHY: Monica Chatwal is a native Floridian, and grew up in Stuart. She received a bachelors degree in biochemistry and molecular biology from the University of Miami. She attended medical school at Florida State University College of Medicine. She then completed her internal medicine residency at Emory University School of Medicine in Atlanta, GA. Currently, she is a third year hematology oncology fellow at Moffitt Cancer Center. She has a particular interest in studying physician resiliency and burnout and incorporating arts and humanities in medicine.

Sharad Khurana, MD- Mayo Clinic BIOGRAPHY: Sharad Khurana, MD, is a current PGY5 in Hematology/Oncology fellowship program at Mayo Clinic in Jacksonville, FL. Alma mater of Grant Medical College in Mumbai, India and graduated in 2013. Dr. Khurana was fortunate to do a masters in clinical research from Rush University while undergoing internal medicine training at John H Stroger Hospital of Cook County in Chicago, Illinois. He has special interest in research in malignant hematology and clinical trials. He hopes to start an academic career after completing fellowship.

Candice Baldeo, MD- Mayo Clinic BIOGRAPHY: Candice Baldeo, MD is the Chief Hematology Oncology Fellow at Mayo Clinic Jacksonville and will graduate in June 2019. She was born and raised in Trinidad and Tobago. After completing medical school in Trinidad, she moved to Jacksonville, Florida for internal medicine residency at the University of Florida, Jacksonville. Dr. Baldeo has a strong interest in Gastrointestinal Oncology and her research has been focused on pharmacogenomics in colorectal cancer.

2018 DIAMOND ELITE CORPORATE MEMBERS  Alexion  Amgen  AstraZeneca

 Bristol – Myers Squibb  Celgene  Genentech  Merck  Pfizer Oncology  Takeda Oncology  Teva Pharmaceuticals

Current as of 10/18/18 2018 DIAMOND CORPORATE MEMBERS

 Astellas Pharma

 Bayer

 Boehringer Ingelheim

 EMD Serono

 Lilly Oncology

 Pfizer Biosimilars

 Sandoz

 Sanofi Genzyme

 Seattle Genetics

Current as of 10/18/18

2018 FLASCO CORPORATE MEMBERS

 AbbVie  Adaptive Biotechnologies  Eisai ®  enterade  Exelixis  Foundation Medicine  Gilead Sciences  Guardant Health  Ipsen  Agios Pharmaceuticals  Heron Therapeutics Biopharmaceuticals  Array Biopharma  Incyte  Novartis  Biodesix  INSYS  Clovis Oncology Therapeutics  Helsinn  Johnson &  Kroger Specialty Johnson Pharmacy  Kite Pharma  Lexicon  NanoString Pharmaceuticals  Oncology Supply/ ION Solutions  Novocure  Pharmacyclics  Quest Diagnostics  Puma  Rigel Biotechnology  Spectrum  Servier Oncology Pharmaceuticals  Sun Pharma  Sysmex  Taiho Oncology  TerSera Therapeutics  Verastem  TESARO  Walgreens Updated as of 4/19/18 FLORIDA SOCIETY OF CLINICAL ONCOLOGY

FLASCO:FLASCO: Download the

“FLASCO” App!

Experience new ways to interact and find the information you need about the Fall Session. Access Meeting Materials, View PowerPoint Presentations, Complete Evaluations and Access the attendee roster by downloading the FLASCO App through your phones App or Play Store. Or scan the QR Code here! Opening Statements & Support Recognition

GENERAL SESSION & MULTI DISCIPLINARY TRACK PROGRAM PLANNING COMMITTEE:

Edgardo Santos, MD, FACP Chairman Ardeshir Hakam, MD, MBA Jose Sandoval-Sus, MD Joseph Rosenblatt, MD Co-VChm Jahanzeb Mohammad, MD, FACP, FASCO Winston Tan, MD Eric Harris, DO Co-VChm Zeina Nahleh, MD, FACP Beau Toskich, MD Seth Berkowitz, LCSW, CCLS Brendan Prendergast, MD Jonathan Zager, MD, FACS

Edgardo S. Santos, MD, FACP~ FLASCO Program Chairman & Board of Directors Member Medical Director of Cancer Research, Thoracic and Head and Neck Cancer Programs, Lynn Cancer Institute/Boca Raton Regional Hospital, and Clinical Associate Professor, Charles E. Schmidt College of Medicine, Florida Atlantic University BIOGRAPHY: Dr. Edgardo Santos practices at the Center for Hematology-Oncology (CHO)/Lynn Cancer Institute where he is the Medical Director of Cancer Research. Dr. Santos is a Clinical Associate Professor at Florida Atlantic University, and the Chairman of the FLASCO Program Planning Committee and Board of Directors Member. He earned his M.D. in 1994 at the University of Panama, School of Medicine, Republic of Panama. Dr. Santos completed his internship and residency training in Internal Medicine at Jackson Memorial Medical Center, University of Miami School of Medicine. He completed his fellowship in Hematology/Oncology at the Sylvester Comprehensive Cancer Center. Dr. Santos has authored or co-authored several manuscripts in peer-reviewed journals and also serves as reviewer for several scientific publications. Dr. Santos is a member of the Editorial Board of Expert Review series, Recent Patents on Biomarkers, and Clinical Practice. Dr. Santos was a former faculty member of University of Miami Miller School of Medicine, Miami, Florida where he held an academic rank as an Associate Professor of Medicine (2008-2012) and Tulane University Health Sciences Center, New Orleans, Louisiana (2004- 2008). Dr. Santos has occupied several administrative, educational, and research leadership positions including Tulane University Principal Investigator at Southwest Oncology Group (SWOG), Associate Scientific Director of Tulane Cancer Center’s Office of Clinical Research, Associate Director of the Fellowship Programs, Chief of the Hematology/Oncology Section at the Southeast Louisiana Veterans Healthcare System, Chair of the Committee Research Advisory Board, Co- Leader of Clinical Research for the Louisiana Cancer Research Consortium, Co-Leader of the Head and Neck Cancer Program at Sylvester Cancer Center, and many others. He is an active member of the International Association for the Study of Lung Cancer where he is the Chair of Publication Committee, member of the Educational Committee for the World Congress on Lung Cancer in 2018 (Toronto, Canada), and the Scientific Chair of 2018 LALCA Congress (Cordoba, Argentina); the American Association for Cancer Research, ASCO, the European Society of Medical Oncology, ASH, and the American College of Physicians-American Society of Internal Medicine. Dr. Santos is also a member of the Addario Lung Cancer Medical lnstitute which is focused in developing personalized medicine in this field. Eric Harris, DO~ FLASCO Program Co-Vice Chairman and Board of Directors Member Florida Cancer Specialists and Research Institute, Daytona Beach, Florida BIOGRAPHY: Eric Harris, DO, is a hematologist/oncologist at Florida Cancer Specialists in Daytona Beach, Florida. Dr Harris has a keen interest in clinical research. He is an active principal investigator on multiple clinical trials with his collaboration with the Sarah Cannon Research Institute. He has been published in Case Reports in Oncology and has presented abstracts and published for several annual scientific meetings, including the Florida chapter of the American College of Physicians and the American Society of Hematology. He is a member ASCO, and serves on the executive committee of FLASCO. Dr Harris received diverse preparation in his early medical training, having been an immunology research technician as well as a supervising medical technologist in a flow cytometry laboratory. He was twice awarded the Gold Key Customer Service Award by UF Health Shands Hospital (2009 and 2014), as well as the Teaching Excellence Award by University of Florida in 2010. Dr Harris earned his DO from Nova Southeastern University College of Osteopathic Medicine in Fort Lauderdale, Florida, and completed a residency in internal medicine and a fellowship in hematology/oncology at University of Florida in Gainesville, Florida where he served as Chief Fellow. He enjoys teaching and is currently part of the clinical faculty at Florida State University and has given multiple community-based and continuing medical educational lectures. Joseph D. Rosenblatt, MD~ FLASCO Program Co-Vice Chairman and Board of Directors Member Chief, Hematology Division, DOM- Miller School of Medicine, University of Miami BIOGRAPHY: Joseph D. Rosenblatt, M.D., is a Professor of Medicine, Microbiology and Immunology, and is Chief of the Hematology Division at the Sylvester Comprehensive Cancer Center (SCCC) at the University of Miami (UM). Dr Rosenblatt joined University of Miami in 2001, bringing extensive administrative and research experience. He holds a graduate cross appointment in the Department of Microbiology and Immunology at UM. Dr. Rosenblatt is also a member of the Sylvester Tumor Biology Program. In the past 20 years, Dr. Rosenblatt has published over 150 journal articles and chapters in the areas of human retroviruses, immune therapies for cancer, and human gene therapy. From 1986 to 1995, Dr. Rosenblatt had been a member of the faculty in Hematology Oncology (Associate Professor) and was elected an Associate Member of the Molecular Biology Institute at the UCLA School of Medicine. Dr. Rosenblatt then served at the University of Rochester from 1995-2001 as the James P. Wilmot Chair in Hematology-Oncology and Chief of the Hematology-Oncology Unit, and had a secondary appointment within the Department of Microbiology and Immunology. He has had continuous NIH and other extramural funding for retroviral, gene therapy and immunotherapy related research since 1986 and has previously been a standing member of the NCI Experimental Therapeutics II (ET-2), the Clinical Immunology and Immunotherapy II (C-II) study sections and more recently as a member of the Clinical Oncology Study section at the NCI. His research includes the synthesis and testing of novel antibody—fusion proteins which target the HER2 and EGFR cancer antigens which can inhibit angiogenesis or augment the immune response to breast and other cancers. He has also developed novel gene therapy approaches for use in lymphoma and chronic lymphocytic leukemia, and is currently exploring the role of B-cells in modulating the immune response to cancer in animal and human cancers. Dr. Rosenblatt completed a Fulbright Scholarship in 1990 at the Rabin Medical Center and is also a founding member of the Bar Ilan Faculty of Medicine in Safed, Israel. He is a nationally recognized expert in the treatment of lymphoma and other hematologic malignancies and maintains an active clinical practice.

GENERAL SESSION ~PRECISION MEDICINE~

Eric Harris, DO~ Moderator FLASCO Program Co-Vice Chairman and Board of Directors Member Florida Cancer Specialists and Research Institute

~PERSONALIZED vs PRECISION? Let’s call it Medicine~

OBJECTIVES: 1. Define Personalized Medicine and related terms. 2. Identify clinical, demographic, and molecular variables that influence personalized medicine. 3. List examples of gene/drug pairs for the clinical application of pharmacogenomics.

Howard McLeod, PharmD Medical Director, DeBartolo Family Personalized Medicine Institute Senior Member, Division of Population Sciences Chair, Department of Individualized Cancer Management, Moffitt Cancer Center State of Florida Endowed Chair, September, 2013-present Professor, University of South Florida, Colleges of Medicine & Pharmacy

BIOGRAPHY: Dr Howard McLeod is Medical Director of the DeBartolo Family Personalized Medicine Institute at the Moffitt Cancer Center. He is chair of the Department of Individualized Cancer Management and a State of Florida Endowed Chair in Cancer Research. He is also a Senior Member of the Division of Population Sciences and Professor at the University of South Florida. Dr McLeod is chair of the NHGRI eMERGE network external scientific panel and a recent member of the FDA committee on Clinical Pharmacology and the NIH Human Genome Advisory Council. Since 2002, Dr McLeod has been vice chair for Pharmacogenomics for the ALLIANCE NCI clinical trials group, overseeing the largest oncology pharmacogenomics portfolio in the world. Dr McLeod is also a 1000 talent scholar of China and a Professor at Central South University in Changsha, China. Howard has published over 550 peer reviewed papers on pharmacogenomics, applied therapeutics, or clinical pharmacology and continues to work to advance individualized medicine.

Florida Society of Clinical Oncology: The Voice of Oncology in Florida

FLASCO 2018 FALL SESSION Saturday, November 10, 2018 Orlando World Center Marriott 8701 World Center Dr│ Orlando, Florida 32821 Multi-Disciplinary Track

10:15 – 11:45 AM Neoadjuvant Breast Caner Zeina Nahleh, MD, FACP, Cleveland Clinic Florida MODERATOR

MEDICAL ONCOLOGY- Mohammad Jahanzeb, MD, FACP, University of Miami RADIATION- Amber Orman, MD, Florida Hospital SURGICAL- Stephanie Valente, DO, Cleveland Clinic Ohio Breast PATHOLOGY- Laila Khazai, MD, Moffitt Cancer Center CASE STUDY- Sofia Palacio, MD, University of Miami

12:45- 2:15 PM

Chronic Lymphocytic Leukemia (CLL) Asher Chanan0Khan, MD, Mayo Clinic Florida—MODERATOR

HEMATOLOGIST- Jan A. Burger, MD, PhD, MD Anderson Cancer Center CLL CASE STUDY- Sonikpreet Aulakh , MD, Mayo Clinic Florida Jeremy Ramdial, MD, University of Miami

2:20 — 3:30 PM Hereditary Genetics focusing on Prostate Cancer Edgardo Santos, MD, Lynn Cancer Institute MODERATOR

MEDICAL ONCOLOGIST- Louise Morrell, MD, Lynn Cancer Institute Jingsong Zhang, MD, PhD, Moffitt Cancer Center PATHOLOGY- Jasreman Dhillon, MD, Moffitt Cancer Center Prostate RADATION ONCOLOGIST- Tim Williams, MD, Boca Raton Regional Hospital CASE STUDY- Brittany Rogers, MD, University of Florida

Don’t forget to turn in your Exhibitor Bingo Cards to be entered into the drawing. Winners will be announced at the end of the program. You must be present to win!

www.FLASCO.org

Multidiscliplinary Track

MULTI DISCIPLINARY TRACK PROGRAM PLANNING COMMITTEE: Edgardo Santos, MD, FACP Chairman Ardeshir Hakam, MD, MBA Jose Sandoval-Sus, MD Joseph Rosenblatt, MD Co-VChm Jahanzeb Mohammad, MD, FACP, FASCO Winston Tan, MD Eric Harris, DO Co-VChm Zeina Nahleh, MD, FACP Beau Toskich, MD Seth Berkowitz, LCSW, CCLS Brendan Prendergast, MD Jonathan Zager, MD, FACS

MORNING TRACK ~NEOADJUVANT BREAST CANCER~ Zeina Nahleh, MD, FACP~ Moderator FLASCO Board of Directors Member Cancer Center Director and Department Chair, Hematology-Oncology, Cleveland Clinic Florida BIOGRAPHY: Dr. Nahleh, is Chair of the Department of Hematology-Oncology and Director of the Cleveland Clinic Florida Maroone Cancer Center. She was previously Professor of Medicine and Chief of the Division of Hematology-Oncology at the Texas Tech University Health Sciences Center, El Paso (TTUHSC-EP) and prior to that Associate Professor and Co-Leader of the Breast Cancer Multidisciplinary team at the Wayne State University-Barbara Ann Karmanos Cancer Institute. Dr. Nahleh subspecializes in breast cancer and has special interests in cancer survivorship and disparities. Her research interests were funded by the National Cancer Institute (NCI), the Cancer Prevention Institute of Texas and other scientific agencies. Dr. Nahleh is a certified principal investigator (CPI) by the Academy of Clinical Research Professionals. She served as a principal investigator in the SWOG oncology cooperative group and has authored national protocols in breast cancer neoadjuvant therapy and male breast cancer. She served on the NCI Neoadjuvant and Metastatic Breast Committees. Dr. Nahleh has received numerous awards, including the Barbara Ann Karmanos Hero of Breast Cancer Award for Scientific Distinction, the TTUHSC Dean’s Excellence in Research Award as well as the Distinguished Chancellor’s Council Award for Research. She has authored and co-authored numerous articles, book chapters and books in the field of cancer and breast cancer research, and has presented at national and international cancer meetings. She serves on the editorial board of numerous medical journals. She has a double American board certification in hematology and oncology.

~Neoadjuvant Breast Cancer Case Study~

Sofia Palacio, MD Hematology/Oncology Fellow, University of Miami, Miller School of Medicine Jackson Memorial Hospital BIOGRAPHY: Dr. Sofia Palacio is the Chief Hematology/Oncology Fellow at the University of Miami, Sylvester Comprehensive Cancer Center. She received her medical degree from CES University in Medellin, Colombia and continued her internal medicine training at University of Miami. She is interested in Breast and Gastrointestinal cancers and her clinical research is focused on Global Oncology. Since starting Fellowship she has authored a number of peer publications and has had poster presentations at national and international meeting including ASCO GI, World Lung and most recently at the San Antonio Breast Symposium.

Mohammad Jahanzeb, MD, FACP, FASCO~ Medical Professor of Clinical Medicine, Division of Hematology/Oncology, Medical Director, University of Sylvester Deerfield Beach, Associate Center Director for Community Outreach, Sylvester Comprehensive Cancer Center, University of Miami, Miller School of Medicine, and FLASCO Board of Directors Member

BIOGRAPHY: Mohammad Jahanzeb is Professor of Clinical Medicine, Hematology Oncology at University of Miami’s Miller School of Medicine. Dr. Jahanzeb currently serves as the Medical Director of UM Sylvester Deerfield Campus and an Associate Director of Community Outreach for the Sylvester Comprehensive Cancer Center. An international lecturer on issues related to breast and lung cancers, Dr. Jahanzeb has given more than 900 lectures as an invited speaker and has authored or contributed to more than 200 original reports, book chapters, reviews, and abstracts. Dr. Jahanzeb is board certified in medical oncology and limits his practice, as well as clinical research, to cancers of the lung and breast. He received his medical degree with high honors from King Edward Medical College at the University of Punjab in Lahore, Pakistan. Dr. Jahanzeb is a fellow of the American College of Physicians, and a Fellow of American Society of Clinical Oncology, and belongs to several professional societies including the American Society of Clinical Oncology, where he serves as the Chair for Quality Oncology Practice Initiative Steering Task Force and is the founding Chair for their task force for International Quality Efforts (iQuality). He is currently a member of the FLASCO Board of Directors. He has also previously served on the Board of Directors and the Expert Panels for Lung Cancer and Breast Cancer of the National Comprehensive Cancer Network between 2003 and 2013.

~Radiation after Neoadjuvant Chemotherapy in Breast Cancer~ OBJECTIVES: 1. To understand current trials examining the role of radiation of breast cancer after neoadjuvant chemotherapy. 2. To understand which patients should be evaluated by a radiation oncologist either before or after neoadjuvant chemotherapy. 3. To understand the anatomical areas typically treated by radiation in various scenarios.

Amber Orman, MD~ Radiation Radiation Oncology Faculty, Breast Section, Radiation Oncology Specialists, Florida Hospital Medical Group Assistant Professor of Radiation Oncology, University of Central Florida (UCF), College of Medicine

BIOGRAPHY: Amber Orman, MD is a board-certified radiation oncologist who specializes in integrative therapies for breast cancer. She joined Florida Hospital Medical Group in May of 2018, with an appointment as Assistant Professor of Radiation Oncology at the University of Central Florida College of Medicine. Previous to this she served as faculty at Moffitt Cancer Center and assistant professor at the University of South Florida Morsani School of Medicine. Her past honors have included an award for best-performing student at her alma mater, Rose-Hulman and selection for the John H. Edwards Fellowship at the Indiana University School of Medicine. She was also peer nominated as a Tampa Top Doctor in 2017. Her research interests include nutrition and gut microbiome modulation in relation to breast cancer prevention, treatment, and survivorship. ~Breast Surgery and Neoadjuvant Chemotherapy~ OBJECTIVES: 1. To identify which surgical patients should be offered neoadjuvant chemotherapy. 2. To learn how response to neoadjuvant chemotherapy directs surgical options. 3. To understand the importance of complete workup and defining patient expectations prior to initiation of neoadjuvant chemotherapy.

Stephanie A. Valente, DO, FACS~ Surgical Assistant Professor of Surgery, Cleveland Clinic Learner College of Medicine and Case Western Reserve University Director, Breast Surgery Fellowship Program, Breast Surgeon, Department of General Surgery, Cleveland Clinic Ohio

BIOGRAPHY: Dr. Stephanie A. Valente is a board- cerfied Breast Surgeon and the Director of the Breast Surgery Fellowship Program at the Cleveland Clinic and Assistant Professor of Surgery at the Cleveland Clinic Learner College of Medicine and Case Western Reserve University. She joined the Clinic in 2011 after completing her Surgical Breast Oncology fellowship at the University of Southern California in Los Angeles. Dr. Valente has a strong interest in advanced surgical techniques including minimally invasive breast surgery, hidden scars, oncoplastic surgery and nipple sparing mastectomy. She has a passion for treating young women with breast cancer, as well as those with genetic andhigh-risk disease. She is active in research for development of innovative surgical procedures to prevent lymphedema. She is also a leader in Intraoperative Radiation Therapy (IORT) serving as 1st author of the TARGIT-R trial, as well as Chair of the Research committee for the TARGIT Collaborative Group for IORT. Dr. Valente has written numerous peer-review journal articles and book chapters in the field of breast cancer and disease and is an active member of both the American Society of Breast Surgeons and Society of Surgical Oncology.

~Updates in Pathologic Evaluation of Post-Neoadjuvant

Chemotherapy Breast Specimens~ OBJECTIVES: 1. Discuss updates on pathologic evaluation of post-neoadjuvant chemotherapy cases, AJCC. 2. Discuss updates on pathologic evaluation of post-neoadjuvant chemotherapy cases, CAP. 3. Discuss current practice (with regards to evaluating post-neoadjuvant breast cases) in the U.S.

Laila Khazai, MD~ Pathology Moffitt Cancer Center

BIOGRAPHY: Dr. Khazai earned her medical degree at the Mashhad University of Medical Sciences in Iran, followed by a residency in clinical/anatomic pathology at Vanderbilt University Medical School. She then completed oncologic surgical pathology, cytopathology and breast pathology fellowships at MD Anderson Cancer Center. Dr. Khazai is board certified in Clinical/Anatomic Pathology and Cytopathology. She is a pathologist at Moffitt Cancer Center, Tampa FL.

AFTERNOON TRACK- SESSION I ~CLL: NEW AND PROJECTED BREAKTHROUGHS~ Asher A. Chanan-Khan, MBBS, MD ~Moderator Professor of Medicine, Mayo Clinic Cancer Center BIOGRAPHY: Dr. Chanan-Khan is the co-leader of the Hematologic Malignancy Program and Professor of Medicine at the Mayo Clinic Cancer Center in Jacksonville, Florida. Dr. Chanan-Khan completed his Fellowship at the New York University School of Medicine. He was the Chief Resident in Internal Medicine while practicing at Harlem Hospital Center, Columbia University College of Physicians and Surgeons. He is board certified in Hematology. Dr. Chanan-Khan treats chronic lymphocytic leukemia, multiple myeloma, and waldenstrom macroglobulinemia. His research interests are multiple myeloma, chronic lymphocytic leukemia, waldenstroms macroglobulinemia, experimental therapeutics, drug resistance in multiple myeloma, novel therapeutics in multiple myeloma, novel therapeutics in chronic lymphocytic leukemia, immunotherapeutic approaches to blood cancers, and preclinical models of multiple myeloma and waldenstroms macroglobulinemia, and CLL. ~Changing Treatment Landscape in (CLL): from chemo-immunotherapy to new targeted agents and individualized therapy~

OBJECTIVES: 1. Discuss CLL risk factors and how they influence treatment outcomes with different classes of agents. 2. Discuss the provided information of pros and cons of targeted agents and conventional chemotherapy-based treatments for CLL patients and how they are best applied to a diverse patient population. Jan A. Burger, MD, PhD Professor of Medicine, MD Anderson Cancer Center-Department of Leukemia The University of Texas BIOGRAPHY: Jan A. Burger, M.D., Ph.D. is a Professor of Medicine at the MD Anderson Cancer Center in Houston, USA. Dr. Burger received his MD/PhD degree at Albert-Ludwigs-University in Freiburg, Germany, with subsequent clinical training and board certification in Internal Medicine and Hematology/Oncology at Freiburg University Hospital, before moving to MD Anderson in 2005. In 2006, Dr. Burger received the “Venia legendi” (Habilitation) for Internal Medicine at Albert-Ludwigs-University in Freiburg. Moreover, from 1996 to 1999, Dr. Burger received postdoctoral research training in Hematology and Immunology at the University of California, San Diego. As a laboratory and clinical investigator, Dr. Burger focuses on developing new therapeutic approaches for targeting the microenvironment in CLL, other B cell malignancies, and acute leukemia. Laboratory research by Dr. Burger’s group characterized B cell chemokine receptors, such as CXCR4 and CXCR5, adhesion molecules, and B cell receptor (BCR)-associated kinases, such as SYK, BTK, and PI3 kinases as therapeutic targets. Dr. Burger serves as a principal investigator on clinical trials which explore several of these targets in CLL. For his innovative research, Dr. Burger has received several awards, among them, the Arthur Pappenheim Award by the DGHO, a Kimmel Scholar Award, ASCO Young Investigator and Career Development awards, the Leukemia and Lymphoma Society Scholar award, and the MD Anderson Faculty Scholar Award. Dr. Burger is a regular speaker at EHA and ASH, and has published in the leading Journals in his field. ~CLL Case Study: High Risk~ Sonikpreet Aulakh, MD~ Fellow Mayo Fellow Liaison, Florida Society of Clinical Oncology Vice-President of Mayo Fellow Association, Mayo Clinic Florida BIOGRAPHY: Dr. Sonikpreet Aulakh is currently in her third year of Hematology Oncology fellowship at Mayo Clinic, Florida. She graduated from medical school in India and completed her internal medicine residency from Wayne State University, Michigan in 2016. She is actively involved in clinical and basic sciences research. She is an aspiring translation neuro-oncologist with research interests on development of novel therapeutics in brain tumors primarily in glioblastomas. ~CLL Case Study: Richter Transformation~ Jeremy Ramdial, MD~ Fellow Hematology/Oncology Fellow, Jackson Memorial Hospital University of Miami Health System, Sylvester Comprehensive Cancer Center BIOGRAPHY: Jeremy Ramdial was born in Middletown, Connecticut and grew up in Kingston, Jamaica. He received his M.D. at the University of Miami Miller School of Medicine, and subsequently did his residency at Jackson Memorial Hospital. As a Resident at Jackson his devotion to teaching and continued learning was evident and resulted in him being awarded Resident of the Year as well as inducted into the Alpha Omega Alpha Honors Medical Society. He went on to his Hematology/Oncology fellowship and has published reports and reviews on a variety of hematology and solid oncology topics. He has taken a keen interest in malignant hematology, specifically in difficult-to-treat and relapsed malignant hematologic disease and has been accepted to a one year fellowship in Stem Cell Transplant and Cellular Therapies, showing his continued pursuit to improve on his current knowledge and therapies for hematologic diseases. SESSION II ~HEREDITARY GENETICS FOCUSING ON PROSTATE CANCER~ Edgardo S. Santos, MD, FACP~ Moderator FLASCO Program Chairman & Board of Directors Member Medical Director of Cancer Research, Thoracic and Head and Neck Cancer Programs Lynn Cancer Institute/Boca Raton Regional Hospital Clinical Associate Professor, Charles E. Schmidt College of Medicine Florida Atlantic University

~Hereditary Updates in Prostate Cancer:

Who, what, why genetic testing for Prostate?~ OBJECTIVES: 1. Understanding the role of genetic germline testing for individuals with prostate cancer or who are at risk for hereditary cancer syndromes? 2. What has changed in our understanding of inherited mutations and contribution to risk of prostate and other cancers? 3. How does this knowledge change management of patients already diagnosed? 4. What is the significance to family members?

Louise Morrell, MD~ Medical Medical Director, Lynn Cancer Institute, Boca Raton Regional Hospital BIOGRAPHY: Dr. Louise Morrell is the Medical Director of the Lynn Cancer Institute in Boca Raton Florida. Her clinical practice is now dedicated to inherited risk assessment and testing for genetic predisposition cancer syndromes through the Morgan Pressel Center for Cancer Genetics. Genetic testing is currently integrated into the multimodality clinics at the Lynn Cancer Institute. The center is a member of the Clinical Cancer Genomics Community of Practice through the City of Hope and participants in the international genetics registry.

~Homologous Recombination Repair Deficiency and its Implications in Prostate Cancer Management~

OBJECTIVES: 1. Understand the function of BRCA2. 2. Understand the clinic utility of different blood test for detecting Germaine versus somatic mutations. 3. Understand the current data on the clinical implications of HRR deficiency.

Jingsong Zhang, MD, PhD~ Medical Associated member, Genitourinary Oncology, Moffitt Cancer Center BIOGRAPHY: Dr. Jingsong Zhang is a genitourinary oncologist at Moffitt Cancer Center. His primary interest is in developing new treatments and biomarkers for prostate cancer and bladder cancer. As a member of the Moffitt experimental therapeutics program, Dr. Zhang has been the Principle Investigator of more than 30 clinical trials. Dr. Zhang has also been actively involved in early phase clinical development of novel therapeutic agents. Among them Durvalumab received accelerated approval by FDA for treating metastatic bladder cancer in May 2017 and Enfortumab was granted FDA breakthrough designation for bladder cancer in April 2018. Dr. Zhang received his medical degree from Peking Union Medical College in China, followed by a Ph.D. in pathology from the University of Southern California. He served as a post- doctoral research fellow at Children’s Hospital Los Angeles, before pursuing a residency in internal medicine at New York Downtown Hospital and fellowship in hematology/oncology at University of Michigan Comprehensive Cancer Center. Dr. Zhang has been published in numerous medical journals and is board certified in both medical oncology and internal medicine Hereditary Aspects of Prostate Cancer OBJECTIVES: 1. Understand genes involved in hereditary prostate cancer. 2. Discuss different syndromes predisposing to hereditary cancer. 3. Discuss testing of hereditary prostate cancer.

Jasreman Dhillon, MD~ Pathology Associate Member, Anatomic (GU) Pathology, Moffitt Cancer Center BIOGRAPHY: Dr. Dhillon is an associate member in the Department of Pathology at Moffitt Cancer Center (MCC) who specializes in GU pathology. Dr. Dhillon has been practicing GU pathology for the last 7 years and is the section head of GU pathology at MCC. She received her fellowship training in GU pathology and Cytopathology at MD Anderson Cancer Center. Dr. Dhillon is actively involved in basic and clinical research and has co-authored more than 30 publications and few book chapters as well.

OBJECTIVES: 1. Review the genetic back ground of prostate cancer. 2. Understand the relationship between BRCA 1 & 2 & prostate cancer. 3. Discuss decision making process for BRCA 2 patients and prostate cancer.

Tim Williams, MD~ Radiation Medical Director, South Florida Proton Therapy Institute BIOGRAPHY: Tim R. Williams, MD, FACR FASTRO is the Medical Director of South Florida Proton Therapy Institute. He has practiced as a board certified radiation oncologist since 1989 in south Florida. He has full medical staff privileges at Boca Raton Regional Hospital and Delray Medical Center and West Boca Medical Center. Dr. Williams completed his undergraduate education at the Georgic Institute of Technology, cum laude, in 1978. His medical education was at the Medical College of Georgia (1983), and his residency was at Shands Hospital of the University of Florida (1987). Before coming to Boca Raton he was Assistant Professor of Radiation Oncology at the Bowman Gray School of Medicine of Wake Forest University. In addition to full-time clinical practice, Dr. Williams is past President (2009) and past Chairman of the Board of Directors (2010) of the American Society for Radiation Oncology. He has also served on the Board of Trustees of the American Registry of Radiologic Technology (2000-2008) and was Chairman in 2006. He has also served as President of the Florida Radiological Society (1999) and received the Gold Medal of the Society in 2013. He has also been a Councilor from the State of Florida to the American College of Radiology and has served on the Colleges’ Council Steering Committee, is the Medical Director for the Radiation Therapy Technology Program at Broward College (1991-present), is a member of the Advisory Board for Radiation Protection for the State of Florida Department of Health, as well as a Research Affiliate Professor in the Department of Physics at Florida Atlantic University. Dr. Williams has edited multiple textbooks in radiation oncology, authored numerous scientific articles, and is a reviewer for the Journal of Contemporary Brachytherapy.

~Prostate Cancer Case Study~

Brittany K. Rogers, MD~ Fellow Hematology/Oncology Fellow, UF Health, University of Florida BIOGRAPHY: Dr. Brittany Rogers is a second year Hematology/Oncology Fellow at the University of Florida. She received her MD from the University of Central Florida College of Medicine and completed internal medicine residency training at the University of Florida. She received the Teaching Excellence Award from the University of Florida in 2017. She is interested in solid tumor cancers, specifically thoracic oncology. She is on the clinical educator focus in her fellowship program. Her research focus is quality improvement and clinical education. She has presented and published abstracts at ASCO Quality Symposium and ASCO Annual Meeting. Florida Society of Clinical Oncology: The Voice of Oncology in Florida

FLASCO 2018 FALL SESSION Saturday, November 10, 2018 Orlando World Center Marriott 8701 World Center Dr│ Orlando, Florida 32821 Pharmacy Track 10:15 – 11:00 AM Welcome Jorge Jonah Garcia, PharmD, MS, MHA, MBA- Baptist Health South Florida

Oral Oncolytics Ray Bailey, RpH, FCS Rx-To-Go-MODERATOR Mabel Arslanyan, PharmD, BCOP–Baptist Hospital of Miami Jessica Unzaga, PharmD, BCPS, BCOP– Memorial Healthcare System

11:00– 12:00 PM Medical Marijuana Victoria Robinson, PharmD– Memorial Regional Hospital Marcos Rejtman, DO, HMDC– Memorial Cancer Institute

1:00-1:55 PM Dina Dumercy McHenry, PharmD, BCOP, BCPS– Baptist Hospital of Miami– MODERATOR

Revenue Integrity Julia Khalil, MD, FCAP– University of Miami Jorge J. Garcia, PharmD, MS, MHA, MBA- Baptist Hospital of Miami

2:00-2:45 PM Patient Assistance Best Practices Sarah Francis, PharmD– Jackson Memorial Medical Center 2:45– 3:30 PM Changes in Oncology Clinical Trials Landcape Anay Moscu, PharmD, BCPS, BCOP– Moffitt Cancer Center

Don’t forget to turn in your Exhibitor Bingo Cards to be entered into the drawing. Winners will be announced at the end of the program. You must be present to win!

www.FLASCO.org Saturday, November 10, 2018 Pharmacy Educational Track

PHARMACY TRACK PROGRAM PLANNING COMMITTEE: Ray Bailey, RPh Dina Dumercy McHenry, PharmD, BCOP, BCPS Amanda Brahim, PharmD, BCOP, BCPS, BCACP Jorge García, PharmD, MS, MHA, MBA, FACHE Melody Chang, RPh Anay Moscu, PharmD, BCPS, BCOP

Jorge J. García, PharmD, MS, MHA, MBA, FACHE Pharmacy Track Planning Chairman, Florida Society of Clinical Oncology Assistant Vice President, System Oncology Pharmacy Service Line Miami Cancer Institute (MCI) Baptist Health South Florida (BHSF)

BIOGRAPHY: Jorge J. García obtained his Doctor of Pharmacy degree from Nova Southeastern University (NSU) College of Pharmacy in 2010. Later that year, he also received a Master of Business Administration (MBA) from the NSU Huizenga School of Business. Dr. García then transitioned to the University of Pittsburgh Medical Center (UPMC) to pursue an ASHP- accredited and combined PGY-1/PGY-2 Health System Pharmacy Administration Residency. As part of this residency program, he also completed a Master of Science (MS) in Pharmacy Administration from the University of Pittsburgh. More recently, Dr. García also completed a Master of Healthcare Administration (MHA) from Florida Atlantic University. Upon completion of residency training, he joined Broward Health Medical Center (BHMC) in Fort Lauderdale, FL, where he served as a Pharmacy Operations Coordinator and Medication Safety Committee co-chair for three years. Dr. García joined the Memorial Healthcare System in 2014 as a Director of Pharmacy for the oncology service line. In this role, he served in multiple committees such as the Oncology and System Pharmacy and Therapeutics Committee, the organization’s Ethics Committee, and led efforts to ensure pharmacy compliance with accreditation entities such as the Commission on Cancer (CoC), the Quality Oncology Practice Initiative (QOPI), and the Oncology Care Model (OCM). Dr. García also founded and chaired the Pharmacy Revenue Integrity Committee and pioneered system efforts to incorporate committee findings in value-based medication management decision-making. In this role, Dr. García significantly impacted financial goals and was the proponent of a fee-for- service to full capitation evolution strategy to leverage value for patients and the organization. Premier Inc. and the Advisory Board are particularly interested in this work and has extended opportunities to Dr. García to speak at national meetings and discuss with the Premier Inc. ACO national cohort. Under his leadership, the Memorial Cancer Institute launched pharmacist- led Oral Oncolytic Management Clinics that worked alongside the Memorial Specialty Pharmacy to deliver high quality specialty pharmaceutical care. Dr. García also successfully led several patient outcomes research projects to further patient care while also providing an opportunity to leverage access to limited-distribution pharmaceuticals. These efforts were integral to successful negotiations to access Pfizer's Limited Distribution Portfolio. Dr. García has served on the ASHP Residency Advancement and the Manager Development Advisory Groups. Dr. García also currently holds several adjunct faculty appointments at different colleges of pharmacy throughout the State. Dr. García has recently served as a speaker at the national level in the areas of specialty pharmacy, biosimilars, alternative payment models, and oncology treatment adherence. Dr. García has worked very closely with FLASCO over the last few years creating an avenue for pharmacy memberships, a pharmacy education track, and currently serves as a FLASCO board of directors member. Dr. García is the recipient of the FLASCO 2018 Above and Beyond Award. Most recently, Dr. García has achieved advanced status as a fellow of the American College of Healthcare Executives (ACHE). Today, Dr. García serves as the Assistant Vice President of Oncology Pharmacy Services at Baptist Health South Florida.

~PHARMACY MORNING TRACK~

Ray Bailey, RPh~ Moderator Pharmacy Track Planning Co-Vice Chairman, Florida Society of Clinical Oncology Director of Pharmacy, Florida Cancer Specialists Rx to Go

BIOGRAPHY: Ray Bailey is responsible for overseeing the operations of Florida Cancer Specialists' Oncology Specialty Pharmacy, Rx to Go, including financial management, business development, new drug access, purchasing contracts and overall formulary management. Bailey was promoted to Director of Pharmacy in 2010, two years after joining FCS as Pharmacy Manager. From 2005 until 2007, Mr. Bailey was General Manager of Walgreens/OptionCare of Southwest Florida. Also, he has been a Staff Pharmacist at Naples Community Hospital, owner of a pharmacy in Pine Island, FL and President/CEO-Owner of OptionCare of Southwest Florida, a national franchise of home infusion pharmacy services. Ray earned his bachelor's and graduate degree from the University of Georgia. SESSION I- ORAL ONCOLYTICS ~Strategies for Optimization of Adherence to Oral Oncolytic Therapies~ OBJECTIVES: 1. Identify barriers that contribute to oral oncolytic nonadherence. 2. Explain direct and indirect methods for measuring medication compliance. 3. Describe available interventions for improving patient adherence to oral antineoplastic therapy. 4. Review best practices for developing an oral oncolytic education and monitoring program.

Mabel Arslanyan, BS, PharmD, BCOP BIOGRAPHY: Mabel Arslanyan, Pharm.D., BCOP, obtained her Doctor of Pharmacy degree from Nova Southeastern University (NSU), College of Pharmacy and proceeded to complete her Pharmacy Practice Residency training at the University of Illinois at Chicago Medical Center. She further pursued specialized training and completed a PGY2 Hematology Oncology residency at Memorial Sloan Kettering (MSK) Cancer Center in New York City. After her residency training she joined the MSK pharmacy team as a Clinical specialist focusing on the areas of leukemia and lymphoma. She then relocated to South Florida and took on the role of Clinical Pharmacy Supervisor at Miami Cancer Institute. She currently holds the position of Hematology- Oncology Medical Science Liaison. Jessica Unzaga, PharmD, BCPS, BCOP Pharmacy Clinical Coordinator Miami Cancer Institute, Baptist Health South Florida BIOGRAPHY: Jessica Unzaga is a Pharmacy Clinical Coordinator at the Miami Cancer Institute at Baptist Health South Florida. She is a graduate of the University of Florida College of Pharmacy and completed her PGY1 and PGY2 residencies at the Nashville VA and Methodist University Hospital, respectively. She carries dual board certification in pharmacotherapy and oncology pharmacy and has a focused interest in malignant hematology and bone marrow transplantation.

SESSION II- MEDICAL MARIJUANA ~Intro Pharmacology to Present Day Advancements~ OBJECTIVES: 1. Define medical marijuana. 2. Review the physiology of the cannabinoid system. 3. Evaluate phytocannabinoids from a pharmacological perspective. 4. Analyze drug interactions commonly seen with cannabinoids. Victoria M. Robinson, PharmD, BCOP Clinical Oncology Pharmacist Emory University Hospital Midtown BIOGRAPHY: Victoria attended Mercer University College of Pharmacy and Health Sciences where she earned her Doctorate of Pharmacy degree in 2011. Her career in oncology began at Grady Memorial Hospital’s Georgia Cancer Center for Excellence a year later. From there, she continued to gain experience in the field of oncology in various settings including hospital-based treatment centers, private practice and specialty pharmacy. She pursued and achieved board certification in oncology in 2017. Victoria enjoys patient counseling, providing nursing education and working behind the scenes to improve safety and outcomes by focusing on workflow and process improvement. She is currently employed at Emory University Hospital Midtown in Atlanta, GA as a member of the oncology computerized-physician order entry (CPOE) team. ~Cannabis Controversies~ OBJECTIVES: • Discuss the potential benefits and risks of cannabis and cannabis derivatives o History & Overview o Derivatives & Formulations o Prevalence of Use o Legal Status:  Federal law  State law, Florida o The Cannabi$ Industry o Recommendations from the National Academies of Science, Engineering & Medicine o Barriers to Research Marcos Rejtman, DO, HMDC Palliative Care Physician, Memorial Healthcare System BIOGRAPHY: Dr. Rejtman is a palliative care physician at Memorial Cancer Institute. He provides care and support for oncology patients and their families. Dr. Rejtman is board certified in family practice, geriatric medicine, and hospice and palliative medicine. He has subspecialiazed in palliative care since 2001, and has developed expertise in non-interventional pain and symptom management. He also understands the critical psychosocial and spiritual challenges facing oncology patients and their families and is fluent in English, Spanish, and Hebrew. Prior to joining Memorial, Dr. Rejtman served as the lead physician for VITAS Palliative Care Solutions and later became the founding medical director of Catholic Hospice. Dr. Rejtman has served on peer review, ethics and quality improvement boards to help optimize patient care and patient experiences at various hospitals. He was also the lead physician at an institutional review board (IRB) for 6 years, assisting in the research of new medications and medical devices. In addition to providing patient care, Dr. Rejtman enjoys teaching the next generation of physicins. He has been involved in medical education since 2009, teaching family medicine, geriatric medicine and most recently serving as a program fellowship dirctor in hospice and palliative medicine.

~PHARMACY AFTERNOON TRACK~ Dina Dumercy McHenry, PharmD, BCOP, BCPS~ Moderator Director of Pharmacy, Miami Cancer Institute BIOGRAPHY: Dr. Dina Dumercy McHenry is currently the Director of Pharmacy at the Miami Cancer Institute of Baptist Health of South Florida. She received her Doctorate of Pharmacy from Florida A & M University and completed a Pharmacy Practice Residency with a focus in Oncology at Jackson Memorial Hospital/ FAMU. She completed an ASHP Oncology Patient Care Traineeship at the University of Texas MD Anderson Cancer Center. She became a Board Certified in Oncology Pharmacy and Pharmacotherapy after working several years in this area of specialty. She has a passion for educating patients and caregivers about cancer treatment, patient safety and increasing cancer awareness.

~SESSION I- REVENUE INTEGRITY~ ~Pharmacy Revenue Integrity & Pharmacy Revenue Management Best Practices~ OBJECTIVES: 1. Discuss charge generation process and Chargemaster management. 2. Review utilization of payer contract terms and payer-mix implications. 3. Discuss Medicare in the context of oncology setting. 4. Review pharmacy audit cases. 5. Discuss pharmacy revenue management strategies through payment model evolution. Jorge J. García, PharmD, MS, MHA, MBA, FACHE Assistant Vice President, System Oncology Pharmacy Service Line Miami Cancer Institute (MCI), Baptist Health South Florida (BHSF) OBJECTIVES: 1. Define Revenue Cycle and Revenue Integrity (RI) in the healthcare field. 2. Review the multifaceted aspects of RI in hospital healthcare. 3. Discuss a multi-disciplinary approach to the RI processes in the quickly evolving field of oncology. 4. Describe ow a multidisciplinary approach can improve accuracy in coding and billing practices to ensure full compliance and maximize legitimate reimbursement. 5. Review various ways pharmacy can support RI efforts. Julia Khalil, PharmD, BCPS Pharmacist – Reimbursement Analyst, UMHC/Sylvester Comprehensive Cancer Center BIOGRAPHY: Julia Khalil is the Reimbursement Analyst Pharmacist at the UHealth/Sylvester Comprehensive Cancer Center. She graduated from the Wingate University School of Pharmacy in 2009 with a Doctor of Pharmacy Degree. Following graduation Dr. Khalil became Board Certified in Pharmacotherapy and has worked as a clinical staff pharmacist in internal medicine at Baptist Health as well as well an ambulatory care pharmacist at Jackson Memorial. Dr. Khalil has been at the UHealth system since 2015. She transitioned into the reimbursement analyst role in 2016.

SESSION II -PATIENT ASSISTANCE BEST PRACTICES OBJECTIVES: 1. Identify opportunities to optimize patient assistance program support within oncology. 2. Distinguish major differences between manufacturer patient assistance program requirements. 3. Develop general guidelines for documentation and maintenance of patient assistance programs. Sarah Francis, PharmD, BCOP Clinical Hospital Pharmacist, Hematology/Oncology Department of Pharmacy Services, Jackson Memorial Hospital BIOGRAPHY: Dr. Francis received her Bachelor’s of Science in Exercise Science from Florida State University and her Doctor of Pharmacy Degree from the Nova Southeastern University. She completed her PGY1 Pharmacy Practice Residency and PGY2 Oncology Pharmacy Practice Residency at Virginia Commonwealth University Health System. Dr. Francis is currently a Clinical Pharmacy Specialist at Jackson Memorial Hospital in Miami, Florida. At Jackson, Dr. Francis serves as the clinical pharmacist for the outpatient Hematology/Oncology clinic and infusion center. In this role, she helps oversee the management of the intravenous and oral oncologic patient assistance program services at Jackson Memorial Hospital.

~SESSION III- CHANGES IN ONCOLOGY CLINICAL TRIALS LANDSCAPE~ OBJECTIVES: 1. Brief overview of history and phases of clinical trials. 2. Identify current challenges in drug development. 3. Define different adaptive designs in clinical trials. 4. Compare traditional and adaptive designs. 5. Discuss the role of pharmacists in clinical research. Anay Moscu, PharmD, BCPS, BCOP Investigational Drug Services Manager Moffitt Cancer Center BIOGRAPHY: Anay Moscu, Pharm.D., BCPS, BCOP, is the Pharmacy Manager at the Moffitt Cancer Center. She graduated from Nova Southeastern University (NSU) in 2003, with a Doctor of Pharmacy Degree. Dr. Moscu is certified in Pain Management and Anticoagulation. She worked as an oncology and pain management specialist at Mercy Hospital from 2003 to 2009 and was the Oncology professor for NSU from 2011-2012. She then she worked at Baptist Hospital of Miami/Cancer Institute as a clinical specialist, pharmacy manager and director. After 8 years, she transitioned to her current role at Moffitt Cancer Center where she oversees Investigational Drug Services. Florida Society of Clinical Oncology: The Voice of Oncology in Florida

FLASCO 2018 FALL SESSION Saturday, November 10, 2018 Orlando World Center Marriott 8701 World Center Dr│ Orlando, Florida 32821 Nursing/Navigator Track

10:15 – 11:00 AM

Beat The Cancer, Save Your Heart Shannon Luker, RN, OCN, CBCN–Parrish Medical Center- MODERATOR Natalee Roper, RN, BSN, CHPN– Moffitt Cancer Center Cathy Elstner Swartzfager– Moffitt Cancer Center Don’t forget to turn in

your Exhibitor Bingo 11:00-11:45 AM Cards to be entered into the drawing. Winners will Navigating Patients: Understanding be announced at the end of the program. Clinical Trials Kate Goodman, RN, BSN– Florida Cancer Specialists—MODERATOR You must be present to win! Christin Hart, RN, BSN, OCN– Florida Hospital Cancer Institute Jose Ortiz-Pagan– Survivor Beth Davison, MSN, RN– Leukemia Lymphoma Society

12:45-2:25 PM Supportive Care Through the Cancer Journey Ana Rosa Espinosa, DNP, MBA, RN, OCN– Memorial Cancer Institute- MODERATOR Adrienne Vazquez-Guerra, MSN, ACNP-BC, AOCNP– University of Miami– MODERATOR PALLATIVE CARE: Mayra Lima, MSN, ARNP, FNP-C– University of Miami PAIN MANAGEMENT: Ana Garcia, ARNP– Memorial Cancer Institute SURVIVORSHIP: Jessica McMillian, DNP, FNP, ARNP-BC– Mayo Clinic Florida

2:30-3:30 PM Shaping The Future of Healthcare Through Nursing Cheryl Habaue, MSN, RN, CCRP– Memorial Cancer Institute- MODERATOR Andrea Uitti, DNP, RN– Florida Action Coalition

www.FLASCO.org Saturday, November 10, 2018 Nursing/Navigator Educational Track

NURSING/NAVIGATOR TRACK PROGRAM PLANNING COMMITTEE: Cheryl Habaue, MSN, RN, OCN, CCRP – Chairman Don Champlain, RN, MHA Shannon Luker, BSN, OCN, CBCN, CN-BN – Vice- Ana Rosa Espinosa, DNP, MBA, RN, OCN Chairman Deborah Hawkins, APRN Seth Berkowitz, LCSW, CCLS Mayra Lima, MSN, APRN, MSN, FNP-C Delmarie Butler, RN, BSHSA, CBHN, CN-BN Adrienne Vazquez Guerra, MSN, ACNP-BC, AOCNP Rosa Caiseda, MSW

MORNING TRACK- SESSION I ~BEAT THE CANCER, SAVE YOUR HEART~ OBJECTIVES: 1. Discuss the importance of a Multidisciplinary Cardio-Oncology program in the management of patients with cancer and cardiovascular disease 2. Discuss the importance of the “Teach back” method, and how this can increase adherence 3. Participants will be able to identify ways to modify cardiovascular risk factors in children and AYA Cancer survivors. Shannon Luker, BSN, OCN, CBCN, CN-BN~ Moderator Oncology Program Coordinator-Breast Health Navigator Parrish Medical Center

BIOGRAPHY: Shannon began her nursing career in 1992. She has been both an intensive care nurse and CVICU nurse but found her calling as an oncology nurse in 2002. She states, “Oncology patients are the reason I have dedicated my last 14 years to cancer care”. She has managed an oncology unit and is currently the oncology program coordinator as well as certified by both the National Consortium of Breast Centers and Oncology Nurses Society as a Breast Health Navigator. She has been in this role for over 4 years and wants to expand into working in the community as an educator, advocate, and resource for cancer screening and cancer prevention in under served communities. Natalee Roper, RN, BSN, CHPN Nurse Coordinator Moffitt Cancer Center BIOGRAPHY: Natalee Roper is a clinical nurse at Moffitt Cancer Center and is the nurse coordinator for the Cardio-Oncology Program. She works closely with the director for the Cardio- Oncology Program at Moffitt to coordinate patient care during their cancer journey. Natalee earned her Bachelor of Science in Nursing at the University of South Florida and has national certification in Hospice and Palliative Care. Prior to starting her career at Moffitt, she spent her early years working on the progressive care, and cardiac post anesthesia care units, where her passion for cardiac care was nurtured. She worked with patients, so they could recover after open heart surgery, lung surgery, and other cardiac procedures. She began her career at Moffitt in 2010, where she worked on the telemetry in-patient unit for 7 years, before she transitioned to the out-patient setting. Cathy Elstner, RN, BSN AYA Nurse Navigator, Moffitt Cancer Center BIOGRAPHY: Cathy has over 25 years of pediatric and adult oncology experience. For the last 8 years her focus has been adolescent and young adult (AYA) oncology; primarily in the Sarcoma department as well as helping to develop the first AYA program in the state of Florida. Last year she transitioned into the unique position of AYA nurse navigator and is supporting young patients in several departments at Moffitt Cancer Center. SESSION II ~NAVIGATING PATIENTS: UNDERSTANDING CLINICAL TRIALS~

OBJECTIVES: 1. Understand how to perform a clinical trials search using clinicaltrials.gov website. 2. Describe the role of Clinical Trials navigators and coordinators. 3. Identify strategies to educate patients about the advantages of clinical trials participation.

Katie Goodman, RN, BSN, CCRP~ Moderator Director of Clinical Research, Florida Cancer Specialists BIOGRAPHY: Katie Goodman is Director of Clinical Research at Florida Cancer Specialists where she oversees the research operations of their early phase research program in Sarasota, FL and late phase programs in 36 community-based locations throughout Florida. Under her leadership, Florida Cancer Specialists currently has a menu of over 100 clinical trials and her team enrolls over 600 patients annually to treatment trials.

Christin Hart, RN, BSN, OCN Urology Cancer Care Coordinator, Florida Hospital Cancer Institute BIOGRAPHY: Christin Hart is an Oncology Nurse Navigator at Florida Hospital Cancer Institute with a focus in Genitourinary Cancers. She started her career in Nursing and love for Oncology in 2003. Christin graduated with a BSN from University of Central Florida and shortly thereafter became an Oncology Certified Nurse. Christin’s 15 years of Oncology experience working in both the inpatient and outpatient Oncology settings has prepared her for her current role as a Nurse Navigator. Christin is most passionate about providing patients with the knowledge and caring expertise needed to navigate their disease throughout the cancer care continuum.

Jose Ortiz-Pagan Survivor BIOGRAPHY: Mr. Ortiz-Pagan was born in Puerto Rico. He served his country and is a veteran of the Vietnam war. Mr. Ortiz-Pagan also served on the New Jersey police force and retired from the profession after years of service. Mr. Ortiz-Pagan was diagnosed with Renal Cell Carcinoma and was given the option of participating in a clinical trial. Mr. Ortiz-Pagan made the decision to enroll and is still currently a part of a clinical trial for the treatment of his kidney cancer.

Beth Davison, MSN, APRN, CNM Clinical Trial Specialist, Clinical Trial Support Center The Leukemia & Lymphoma Society

BIOGRAPHY: In her role as a Clinical Trial Specialist, Beth Davison helps in the Leukemia & Lymphoma Society’s efforts to educate and assist individuals that have been affected by blood cancers regarding the treatment option of clinical trials. Patients who may benefit from expanded clinical trial support services are referred to her by her colleagues in the Information Resource Center (IRC), the first point of contact for many patients affected by a blood cancer. Through education, advocacy, coaching and decision- support services, she and her peers help patients weigh their unique concerns around receiving care through standard treatment or within a clinical trial. LLS is the world’s largest voluntary health agency dedicated to blood cancer. The mission of the Leukemia & Lymphoma Society is to cure leukemia, lymphoma and myeloma, and improve the quality of life of patients and their families. Prior to LLS, Beth held a position as a Certified Nurse Midwife at Reading Health Care System in Reading, PA. In her early career, she worked in many areas of nursing including: Correctional, Public Health, and Case Management. Beth graduated from the University of St. Francis with a Bachelors in Science Nursing, and obtained her Master’s degree in Nursing with a specialty in Midwifery from Frontier Nursing University. She resides in St. Augustine, FL with her husband and three children Tristan, Nyna, and Rylan. AFTERNOON TRACK- SESSION I ~SUPPORTIVE CARE THROUGHOUT THE CANCER JOURNEY~ Ana Rosa Espinosa, DNP, MBA, RN, OCN~ Moderator Administrative Director Oncology Clinical Services, Memorial Cancer Institute BIOGRAPHY: Dr. Ana Rosa Espinosa is the Administrative Director of the Oncology Clinical Services at Memorial Cancer Institute. In her role she oversees the practice of all nursing and APRN’s. She is an exceptional Nursing Director with extensive education in nursing as well as business development skills . She has been in the oncology field for most of her long nursing career, and is Oncology certified. She has a Doctor of Nursing Practice from the University of Miami, a Masters in Business from Nova Southeastern University and a Bachelors in Nursing from Barry University . She is a speaker, has published several nursing articles and has an interest in nursing research. She is promoter of higher education and supporter of nursing research and evidence-based practice. Prior to Joining Memorial Cancer Institute, she was the Nursing Director for the Outpatient Clinics at Sylvester Comprehensive Cancer Center. She is a member of the Florida Nursing Association and the Oncology Nursing Society. She is an active member in her community and is involved in many cancer events. Adrienne Vazquez Guerra, MSN, ACNP-BC, AOCNP~ Moderator Survivorship Operations Leader, University of Miami, Sylvester Comprehensive Cancer Center BIOGRAPHY: Ms. Adrienne Vazquez is a board certified acute care nurse practitioner. She studied at Barry University in Miami Shores for both her undergraduate and graduate degrees and is a Sigma Theta Tau member since her 2004 induction. Ms. Vazquez worked in the inpatient unit and bone marrow transplant unit at Jackson Memorial Hospital, in thoracic/head and neck oncology and as the infusion nurse practitioner at the University of Miami Sylvester Comprehensive Cancer Center. She was awarded the 2013 Nurse Practitioner of the Year at Sylvester Cancer Center. In early 2015 she was offered a position at Memorial Sloan Kettering Cancer Center in New York City within the department of thoracic oncology managing patients on clinical trials. She returned back to South Florida and accepted a position as the Operations Leader of the University of Miami Survivorship and Precision Medicine programs. She is currently the director of the clinical Survivorship program at Sylvester Cancer Center and has had numerous abstracts and papers written on the topic. Ms. Vazquez is an Advanced Oncology Certified Nurse Practitioner® (AOCNP) and is the current chair of the item writing and test development national committees for the AOCNP board exam. She has attended numerous medical missions to South America and Project Medishare in Haiti. In August 2014 she volunteered to be the nurse at Camp Kesem (a camp for children whose parents have cancer). ~Palliative Care~ OBJECTIVES: 1. Describe current trends in Oncology care today 2. Articulate key issues for patients, families, and healthcare systems related to cancer diagnosis, treatment, goals of care, etc. Mayra Lima, APRN, MSN, FNP-C Breast Cancer Treatment and Prevention Program, Sylvester Comprehensive Cancer Center, UM BIOGRAPHY: Mayra Lima has been a Registered Nurse since 1985 (30 years). She has worked in many different roles such as ER, Ophthalmology, Surgery, Disease Case Management, and Director of Nursing. She accomplished this all the while continuing her education and completing her Bachelor's degree at FIU, followed by the Masters in Nursing Science and Family Nurse Practitioner with a Certificate in Gerontology by December of 2000. As an nurse practicioner, Ms. Lima, has dedicated her work to oncology and solid tumors in GI and Research at University of Miami/Sylvester for 6 years. Ms. Lima decided to dedicate herself to helping those with breast cancer once she became a survivor of breast cancer herself. She has worked with breast cancer patients for the past 9+years. Recently she relocated from the Memorial Breast Cancer Center to the Sylvester Breast Cancer Center in Plantation. In her personaI life she loves to travel, arts & crafts, dancing, music and all within the context of her family. Ms. Lima’s survival of breast cancer propelled her to do half marathons. Since 2007 she has completed 16. Ms. Lima also has a love of knowledge, she is a recent alumna of the Cancer Genetics Risk Assessment Program. ~Florida’s New Law on Controlled Substance Prescribing~ OBJECTIVES: 1. Discuss the opioid epidemic. 2. Discuss the HB 423 bill. 3. Discuss the Florida Law on Controlled Substance Prescribing Prior to HB21. 4. Discuss the Florida Law on Controlled Substance Prescribing After HB21. Ana B. Garcia, APRN, MSN, FNP Oncology Supportive Care Services (Palliative Care/Pain Management) Memorial Cancer Institute BIOGRAPHY: Ana Garcia is an Advanced Registered Nurse Practitioner, specializing in Oncology Supportive Care Services (Palliative Care/Pain Management). Ana received her Bachelor’s of Science in Nursing and Master’s of Science in Nursing at Florida International University in Miami, Florida. She began her career as a Medical Doctor in Colombia when she graduated from Libre University in Cali, Colombia (1995). In 2000, she completed her Master’s in Occupational Health at Libre University. She worked for a primary care physician and Occupational Health Physician in Colombia for serveral years. She migrated to United States and attended the program at Florida International University for foreign trained doctors to become nurse practitioners. She received her Bachelor of Science in Nursing (BSN) in 2012 graduating Summa Cum Laude and received her Master’s of Science in Nursing (MSN) as a Family Advanced Nurse Practitioner in 2013. She received her National Certification from American Assocation of Nurse Practitioners (AANP). After graduation, she worked in Bradenton, Manatee County as a Family Nurse Practitioner in a primary care setting for 2 years. In August of 2015, she joined the Memorial Cancer Institute (MCI), Oncology Supportive Care Services (Palliative Care/Pain Management) to provide quality care to Memorial Cancer Institute (MCI) patients, as part of a multidisciplinary team. Ana has been in the healthcare field for over 20 years. ~Survivorship~ OBJECTIVES: 1. Define supportive care. 2. Discuss care needs of individuals during and after cancer treatment. 3. Describe supportive care interventions that are patient specific. 4. Identify care needs of individuals facing advanced and/or progressing cancer across all domains of health. 5. Review interventions to optimize functional abilities at the end of life, consistent with patient preferences. Jessica McMillan, DNP, FNP, APRN-BC Breast Cancer Treatment and Prevention Program Mayo Clinic Florida BIOGRAPHY: Dr. McMillan has been a member of the Mayo Clinic staff since 1998, in multiple roles. Currently, she serves as an Advance Practice Provider in the Department of Hematology/Oncology since 2010. She has also worked as a Clinical Nurse Educator and Charge Nurse/Team Leader in the surgical Intensive Care Unit. Dr. McMillan obtained her family Nurse Practitioner Certification from the University of North Florida in 2009, and went on to obtain her Doctorate of Nursing in Family Practice with a Sub-specialty in Palliative Medicine in 2015. She serves as a preceptor for physician assistant and nurse practitioner students at Mayo Clinic Florida School of Medicine. She also works as a Adjuvant Instructor for the University of North Florida where she inspires and mentors future nurses. She is very active with the Florida Society of Clinical Oncology and the Northeast Florida Advance Nurse Practitioner Association.Within the Division of Hematology/Oncology, she specialiezes in Gastrointestinal Tumors but serves as a resource in all areas of solid tumors for her feelow coleagues. Her passion is patien care and education. She feels very fortunate to work with cancer patients where she able to utilize her skills and education to forge relationships for patients who face uncertain futures. SESSION II ~SHAPING THE FUTURE OF HEALTHCARE THROUGH NURSING~

Cheryl Habaue, MSN, RN, OCN, CCRP~ Moderator Nursing/Navigator Track Chairman Florida Society of Clinical Oncology Clinical Research Nurse BIOGRAPHY: Cheryl Habaue received her BSN from Mount Mercy College in Cedar Rapids, Iowa and MSN from Chamberlain College of Nursing. She has been in research for the past 6 years working on studies related to all cancers including but not limited to Lung, Breast, GI, GYN, GBM, Leukemia, Multiple Myeloma, Lymphoma, Head and Neck, as well as Sarcomas and Melanomas. Cheryl currently works on phase I-IV clinical trials, focusing on trial management, process improvement and project management.

OBJECTIVES: 1. Discuss ethical rationale for Action. 2. List the Action steps. 3. List the approaches that strengthen the profession including facilitate policy change on many levels and influencing institutional, community, and statewide policies

Andrea Uitti, DNP, RN Associate Director of Research Programs and Services Florida Center for Nursing Florida Action Coalition BIOGRAPHY: Dr. Andrea Uitti is the Associate Director of Programs and Grants, Florida Center for Nursing & the Florida Action Coalition. In this role, she works to help nurses transform healthcare in Florida. Drawn to the Florida Center of Nursing’s innovative and strategic vision to address all nursing workforce issues in Florida, she is helping to promote purposeful interventions in our states primary areas of need. Andrea successfully led grants that provide leadership training for nurses, research, educational, and collaboration opportunities for the nursing community in Florida. Accomplished with the unwavering support and funding from the Florida Blue Foundation, leadership of the Florida Action Coalition, and our national partners AARP & RWJF. Her current goals include engaging nursing groups and community members to play a vital role in educating the public and policymakers. Working to build a critical mass of awareness, and channeling public concern about our state healthcare crisis into effective action. Previously, Andrea worked in cultural and medical anthropology, both in Mexico and with the Choctaw Indians, with a focus on diabetes. The Mott Foundation Safe Energy Communication training, media skills training and outreach strategies helped her begin her career working with volunteers and coalitions. Andrea served on environmental committees and task forces, providing recommendations to the public and policymakers. She built effective general media and targeted communication campaigns to achieving environmental protection policy goals in Birmingham, Alabama. Dr. Uitti received a DNP at Samford University, with a focus on policy and administration. As an RN she practiced as an ICU nurse, while completing a master’s degree in nursing education. She also earned a bachelor’s degree in anthropology. Florida Society of Clinical Oncology: The Voice of Oncology in Florida

FLASCO 2018 FALL SESSION Saturday, November 10, 2018 Orlando World Center Marriott 8701 World Center Dr│ Orlando, Florida 32821 Administrators Track 10:15 – 11:45 AM Difficult Conversations Beth Sussman, Executive Coach –SPEAKER

Discussion Panel COMMUNITY BASED- Gail Erentreich, Cancer Care Centers of Brevard HOSPITAL BASED- Abby Castillo, Moffitt MHCT at Memorial ACADEMIC CENTER- Josh Mattson, Mayo Clinic Florida

12:45- 2:25 PM Don’t forget to turn in your Exhibitor Bingo Cards to be Prior Authorizations entered into the drawing. Sarah Cevallos, Florida Cancer Specialists- MODERATOR Winners will be announced at PANELISTS the end of the program. David Segal, Aetna Andrew Hertler, MD, New Century Health You must be present to win! Maen Hussein, MD, Florida Cancer Specialists Amanda Brahim, PharmD, Memorial Healthcare System Shelli Johnson, Cancer Care Centers of Brevard Candice Banks, Cancer Survivor

2:25 - 3:00 PM Patient Collections Shelli Johnson, Cancer Care Centers of Brevard

www.FLASCO.org Saturday, November 10, 2018 Administrator Educational Track Non - CME

ADMINISTRATOR TRACK PROGRAM PLANNING COMMITTEE: Gail Erentreich Sarah Cevallos Maggie Wiegandt, MBA Shelli Johnson

WELCOME

Maggie Wiegandt, MBA The Memorial Healthcare System

BIOGRAPHY: Maggie Wiegandt has been a healthcare administrator for over 15 years. In her current role as Administrative Director for Outreach and Liaison Development, she leads business development and philanthropic activities for the Memorial Cancer Institute Adult Specialties and Joe DiMaggio Children’s Hospital. In her past role as Vice President of Oncology Services, she was responsible for providing programmatic, operational and strategic leadership to further the growth, improved outcomes and integration of cancer services within the Memorial Healthcare System. Memorial is located in Broward County and it the 3rd largest public healthcare system in the nation.

Maggie’s involvement and collaboration with community Oncology partners has been critical to improving the cancer care provided at Memorial Cancer Institute. Her community commitments have included Gilda’s Club of South Florida Executive Committee Board Member, American Cancer Society Board Member, Making Strides Against Cancer Committee Chair, Pink Angels of the Memorial Foundation Executive Committee Member, and Past Chair of the Board for Miramar/Pembroke Pines Chamber of Commerce. Awards include 1,000 Plus Woman of the Year, Hispanic Woman of Distinction and South Florida Business Journal Up and Comers.

Maggie earned her Bachelor of Science Florida State University and a combined Master of Healthcare Administration and Master in Business Administration from the University of Houston. She lives in Palm Beach County with her family.

~DIFFICULT CONVERSATIONS~

Beth Sussman Beth Sussman Consulting, LLC

BIOGRAPHY: Beth Sussman is an experienced consultant, leader, facilitator and executive coach with proven experience working with start-ups to large, global organizations in industries such as healthcare, pharmaceutical, professional and financial services, technology, commercial real estate, building services, not-for-profit, publishing, educational services, manufacturing, staffing and retail. With both internal executive leadership and business consulting experience, Beth has led organizational transformations and facilitated the development of business, process and people strategies from within leadership teams and for her clients. Beth provides a unique blend of subject matter expertise, energy, insight and creativity to help organizations quickly and efficiently create and implement the best solutions to support their goals.

Beth works with clients on a broad range of talent and organizational issues. A sample of her experience includes: facilitating strategy sessions and panel discussions; designing and implementing talent management processes and programs across all stages; creating organization-specific competency models; redesigning organizations including processes, roles, structure and people for leadership and other functional groups; designing, developing and facilitating leadership, individual and team development; coaching and advising business leaders to improve performance; and redesigning human resource organizations and people strategies. Beth has a Bachelor’s Degree in Organizational Psychology and a Master’s Degree in Labor and Industrial Relations, both from the University of Illinois in Champaign. She is Certified Coach, Facilitator and Trainer in the following: The Leadership Circle, PDI 360 Degree Feedback, Myers Briggs and DISC. Beth has served as a member of the Board of Directors of Working in the Schools as well as the Leadership Council for Metropolitan Open Communities

~DIFFICULT CONVERSATIONS PANELISTS~

Abby Castillo Moffitt MHCT at Memorial

BIOGRAPHY: Abby Castillo, is the Program Director for the Moffitt Malignant Hematology & Cellular Therapy Program at Memorial Healthcare System. She is responsible for the operational management and support of the new Moffitt Cancer Center partnership at Memorial. She collaboratively oversees interdepartmental operations and facilitates optimizations for team members, patients and families while ensuring excellence in patient care for the Heme-Malignancies and Bone Marrow Transplant program. Abby has established her professional career over the past 19 years working for major universities and healthcare systems in Missouri, Illinois and Florida. Before joining the Memorial team, she was responsible for capital projects for system wide strategic and facility initiatives at Jackson Health System in Miami. Previously at Memorial she led the Enterprise Portfolio Program Management Office for Strategic Planning. Abby received her Bachelor’s degree from Southern Illinois University Edwardsville with a major in Construction Management, followed by a MBA from Florida International University with a focus in Healthcare. Abby sits on the Broward Board for Leukemia Lymphoma Society, is a committee chair for Tour de Broward, an active volunteer in the Memorial Healthcare System H.E.R.O.s program, and her and her husband have a non-for-profit that provides school supplies for children in Nicaragua.

Gail Erentreich Cancer Care Centers of Brevard

BIOGRAPHY: Gail has been in the healthcare industry since 1982 and Medical Oncology since 1986. She went to Fisher College in Boston and then moved to the west coast and lived in Los Angeles from 1982 to 1986 where she managed a general medicine and cardiology practice. Dr. Edward Knight, Gail’s father, was a practicing Medical Oncologist in Rockledge, Florida. He asked her to come and run his practice in 1986 and even though she wasn’t sure she wanted to work for her father, she accepted and has been in the same office for almost office for 32 years as the Director of Clinical Services for Cancer Care Centers of Brevard. Gail has preceded all of the 7 Medical Oncologists currently practicing at Cancer Care Centers of Brevard. Medical Oncology has been very challenging and yet, she can’t think of doing anything else. Gail worked with the University of Central Florida and Oncology Managers of Florida to develop a certificate program specific to the Management of Medical Oncology which was repeated at UCF 4 times. Gail has been on the board of Oncology Managers of Florida since 1992 and after holding the position of President in 1997and 2007, she continued as Vendor Coordinator. Gail’s claim to fame was when she was 6 years old and lived in Stockbridge, Massachusetts she went on a house call to Norman Rockwell, the famous illustrator’s house with her father.

Josh Mattson Mayo Clinic Florida

BIOGRAPHY: Joshua Mattson is an Operations Administrator for Cancer Programs at Mayo Clinic in Florida. In his current role, he oversees operations for Hematology Oncology, Radiation Oncology, BMT, Center for Breast Health and serves as Administrator for Mayo Clinic enterprise Breast Cancer Service line and enterprise Radiation Oncology. Mr. Mattson has worked in healthcare for 19 years and has been a part of the Mayo Clinic team since 2007. Prior to joining Cancer Programs, he held positions within the Revenue Cycle and the Department of Transplantation. Most recently, Mr. Mattson was the Clinical Operations Manager for Cancer Programs at Mayo Clinic in Florida where he was responsible for day to day clinic operations. Mr. Mattson holds a Bachelor of Arts degree in Business Administration from the University of North Florida and the Master of Business Administration from Florida International University. He is a member of the American College of Healthcare Executives and Northeast Florida Medical Group Management Association. In addition, he is a member of the North Florida Leukemia and Lymphoma Society Light the Night Executive Committee. Mayo Clinic Florida Cancer Center, an NCI designated Comprehensive Cancer Center is located in Jacksonville, Florida. In 2017, the State of Florida recognized for a second time as a State of Florida Cancer Center of Excellence. The Jacoby Center for Breast Health at Mayo Clinic Florida is accredited by the NAPBC and was recognized as a Best Practice for Interdisciplinary Patient Management.

Administrator Educational Track-Afternoon Session

~PRIOR AUTHORIZATIONS~

Sarah Cevallos~ Moderator Florida Cancer Specialists & Research Institute American Oncology Network, LLC

BIOGRAPHY: As Chief Revenue Cycle Officer for Florida Cancer Specialists and American Oncology Network (AON), LLC, Sarah Cevallos is responsible for patient financial services, billing, timely collection, and precise payment posting, while delivering a positive patient experience. Sarah is also responsible for fostering payer partnerships and leads the value-based care initiatives to enhance quality payment programs to support the delivery of high quality cancer care to patients for the network of providers. Also, Sarah serves as Clinical Practice Committee Member for the Florida Association of Clinical Oncology (FLASCO) and works closely with the Community Oncology Alliance (COA) on reimbursement and practice transformation strategies towards value- based care. She has been recognized by the Florida Society of Clinical Oncology (FLASCO) as the inaugural recipient of the Distinguished Service Award for her continued support of facilitating resolution of reimbursement issues for oncologists in Florida. Sarah holds a Bachelor of Science degree in Business Management from Nova Southeastern University and an MBA degree from Western Governors University with a concentration in Healthcare Management. Sarah has been quoted and interviewed by the American Journal of Managed Care (AJMC) on various topics ranging from the Oncology Care Model (OCM) to collecting patient data to drive decisions.

David Segal Aetna

BIOGRAPHY: As Network Vice Present of Network Management with Aetna, David Segal is responsible for the Tampa / Southwest Florida local market managing the entire provider relations and healthcare contracting team. He has more than 22 years of healthcare experience with Aetna and over 16 years collaborating directly with Florida healthcare providers. Through the years David has received numerous awards from the National Winner’s Circle (for most improved hospital deal) to national recognition in helping with the development of Aexcel in 2004, one of Aetna’s first performance networks. He currently is a voting member for the Southeastern United States for Aetna’s network steering committee which determines national network strategy. David has always been collaborative with providers to come up with ways to keep healthcare more affordable. David Graduated from Jacksonville University with a Bachelor in Business Administration majoring in business administration and business management and enjoys cruising the Caribbean with his family.

Andrew Hertler, MD New Century Health

BIOGRAPHY: Dr. Hertler, as the CMO of New Century Health, is responsible for the advancement of the company’s clinical quality and value-based strategy, utilization management policies and clinical thought leadership initiatives. A practicing board certified oncologist for 30 years, he is a nationally recognized leader in oncology clinical practice. Dr. Hertler has volunteered on a number of American Society of Clinical Oncology (ASCO) committees, including the Clinical Practice, Quality of Care and Payment Reform Committees, as well as the Quality Oncology Practice Initiative Certification Program Oversight Council.

Maen Hussein, MD Florida Cancer Specialists

BIOGRAPHY: Dr. Hussein has participated in numerous trials and he’s one of the Principal investigators for lung cancer trial within Florida Cancer Specialists & Research Institute. He encourages qualified patients to consider participating in clinical trials not only because of the future development of new therapies, but because patients who participate often receive a promising new therapy even before it is approved for general use. Dr. Hussein is an active participant and long standing member of the Florida Society of Clinical Oncology. He is the FLASCO Treasurer and an invaluable contributor on the Board of Directors.

Amanda Brahim, PharmD Pharmacy Track Co-Vice Chairman Memorial Healthcare System Pharmacy Continuing Education Liaison

BIOGRAPHY: Amanda Brahim, Pharm.D., is the Clinical Pharmacy Manager for Hematology/Oncology at Memorial Healthcare System. She holds a position on the American Society for Blood and Marrow Transplant Pharmacy SIG membership committee and American College of Clinical Pharmacists (ACCP) Hematology-Oncology PRN task force. Dr. Brahim received her Doctor of Pharmacy degree from Palm Beach Atlantic University in West Palm Beach, Florida in 2011 and completed a pharmacy practice residency at Cleveland Clinic Florida. Dr. Brahim is Board Certified in Oncology, Pharmacotherapy and Ambulatory Care. She holds professional memberships with ASBMT, ACCP, ASHP and HOPA.

Shelli Johnson Cancer Care Centers at Brevard

BIOGRAPHY: Shelli Johnson has more than 20 years of healthcare experience in both the provider and insurance arenas. The focus of her career for the last 15 years has been in community based oncology, providing administrative, financial counseling, and AR management for cancer and hematology patients in Brevard and Indian River Counties. Her unique experience has allowed her to pursue her goals of providing not only excellent care to her patients, but equal and affordable access to care for all patients in need regardless of their situation. Shelli attended Ohio State University and Keiser University. She currently lives in Palm Bay, Florida and enjoys spending time with her husband, and two sons.

Candice Banks Cancer Graduate

BIOGRAPHY: My name is Candice Banks. I am a forty-two-year-old wife and mother of two sons. Before breast cancer, I was a very active individual. We would go on family camping trips to the Keys, Kayak along the Indian River, fish with my family, and participate in a multitude of outdoor activities. Having Breast Cancer has impacted that a bit leaving me drained of energy and have random pains everywhere. I am a warrior. A fight for my life. When asked to write a biography about myself it was difficult for me. The reason for this is that it is hard for me to remember my life without cancer, because my wife and I have been completely consumed with it in every aspect. Living and breathing breast cancer. Now, friends and even strangers call me an inspiration; reaching out to me for guidance, advice, and support for their individual breast situations.

I have been blessed with a huge support group throughout this journey and I am making new breast cancer fighter/survivor friends. Today, I get privilege to tell my story to whoever wishes to hear it. I’ve been asked to speak at the FLASCO Fall Session, and am becoming a voice for something I believe in and have worked hard for; what an honor. It hasn’t even been a year that I have been fighting breast cancer, but I’ve already grown from the experience and I will continue to grow and beat it.

~PATIENT COLLECTIONS~

Shelli Johnson Cancer Care Centers at Brevard

Brandy Cunningham Cancer Care Centers at Brevard

Florida Society of Clinical Oncology: The Voice of Oncology in Florida

2018 FLASCO FALL SESSION EXHIBITORS

AbbVie Pharmaceuticals Heron Therapeutics Shire Adaptive Biotechnologies® IBM Watson Healthcare SMP Pharmacy Solutions Agios Pharmaceuticals ICU Medical Inc. Infusion Spectrum Pharmaceuticals Alexion Pharmaceuticals Systems Specialist Sun Pharma AMAG Pharmaceuticals Incyte Surterra Wellness Amgen Ipsen Biopharmaceuticals Taiho Oncology Array Biopharma Jazz Pharmaceuticals Takeda Oncology Astellas Pharma Johnson & Johnson Tempus AstraZeneca Kite Pharmaicon TESARO Bayer Healthcare Kroger Specialty Pharmacy TEVA Pharmaceuticals Biodesix Lexicon The Leukemia and Boehringer Ingelheim Lilly Oncology Lymphoma Society BriovaRx McKesson Specialty Health UF Health Cancer Center Bristol-Myers Squibb Merck Varian Medical Systems BTG International Mitra Biotech Verastem Oncology Caris Life Sciences Moffitt Cancer Center Walgreens Specialty Celgene Myriad Genetics Pharmacy Cleveland Clinic nanoString Technologies Clovis Oncology NantHealth Coherus Novartis Daiichi Sankyo, Inc. Novocure Eisai, Inc. Oncology Supply/ION EMD Serono Solutions enterade® Pfizer Biosimilars Exelixis Pfizer Oncology Florida Cancer Data System Pharmacyclics Foundation Medicine Puma Biotechnology Genentech Quest Diagnostics Inc. Genomic Health Rigel Pharmaceuticals Gilead Sciences Roche Diagnostics Guardant Health RxVantage Health Council of South Sandoz Florida Sanofi Genzyme Helsinn Therapeutics Seattle Genetics Servier Pharmaceutical

As of 10/24/2018 In an effort to increase engagement among physicians, clinicians and administration (including attendance at events), the FLASCO Board of Directors agreed to extend complimentary membership through December 31, 2020 for physicians and their supporting staff from private practices, academic centers, and hospitals in the Florida Oncology community.

The Florida Society of Clinical Oncology THANKS our 100% Membership Partners!

• Broward Health • Cancer Care Centers of Brevard • Cancer Center at Larkin • Cancer Specialists of North Florida • Cleveland Clinic Florida • Eugene M. & Christine E. Lynn Cancer Institute, Boca Raton Regional Hospital • Florida Cancer Specialists & Research Institute • Florida Hospital Gynecologic Oncology • H. Lee Moffitt Cancer Center • Memorial Cancer Institute/Memorial Healthcare System • Miami Cancer Institute-Baptist Health South Florida • Michael &Dianne Bienes Comprehensive Cancer Center, Holy Cross Hospital • Mid Florida Cancer Centers • Oncology & Hematology Associates of West Broward • Orlando Health-University of Florida Health Cancer Center • Suncoast Cancer Institute • Sylvester Comprehensive Cancer Center, University of Miami • University of Florida Health Cancer Center, Gainesville • Winter Haven Hospital Cassidy Cancer Center • Women’s Care Florida

As of October 18, 2018 2018 FLASCO FALL SESSION

November 9 & 10, 2018

ACCREDITATION STATEMENTS

The Medical Educator Consortium

Accreditation Statement: In support of improving patient care, this activity has been planned and implemented by the Medical Educator Consortium and the Florida Society of Medical Oncology. The Medical Educator Consortium is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Designation Statement: The Medical Educator Consortium designates this live activity for a maximum of 6.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Statement: The Medical Educator Consortium (MEC) adheres to the ACCME Standards for Commercial Support. All persons that will be in a position to control the content of the CME Activity are required to disclose all relevant financial relationships. Faculty disclosure forms outlining this information will be made available to all participants prior to educational activity. MEC has also implemented a mechanism to identify and resolve all conflicts of interest prior to the education activity being delivered to learners. The source of all support from commercial interests will also be disclosed to learners prior to the beginning of the educational activity.

The Leukemia & Lymphoma Society

Approval for nurses has been obtained by the Southern Florida Chapter of The Leukemia & Lymphoma Society under provider number 50-12996 (Expiration Date: 10/31/20) to award up to 6.5 contact hours through the Florida Board of Nursing.

Memorial Regional Hospital The FLASCO Fall Meeting for MEMORIAL REGIONAL HOSPITAL developed and presented for Florida Board of Pharmacy professionals has been approved and registered for 6.5 contact hours. FACULTY DISCLOSURE (onsite distribution)

2018 FLASCO FALL SESSION November 9-10, 2018 Orlando, FL

The Medical Educator Consortium in accordance with the Accreditation for Continuing Medical Education (ACCME) Standards for Commercial Support will disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services by anyone in control of content.

As a Joint Accreditation (JA) Provider decisions in the planning process of this conference were made free of the control of commercial interests. All individuals who are in a position to control the content of this educational activity have disclosed all relevant financial relationships with any commercial interest to the provider. In accordance with the JA Provider’s Conflict of Interest & Resolution Policy, any conflict of interest pertaining to this CME Activity have been resolved. This disclosure includes all persons in control of content to include staff and educational committee members involved in the planning process.

The ACCME defines a “commercial interest” as any entity producing, marketing, re-selling, or distributing health care goods or services, used on, or consumed by, patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests

Speakers/Moderators/Presenters Monica Bertagnolli Has no relevant financial relationships Jan Burger Has no relevant financial relationships Asher Chanan-Khan Has no relevant financial relationships Eric Harris Consultant: AstraZeneca, Bristol Meyers Squibb, Novartis Speakers’ Bureau: Bristol Meyers Squibb, Amgen, Novartis Dhillon Jasreman Has no relevant financial relationships Mohammed Jahnazeb Grant/Research Support: Lilly, Boehringer-Ingelheim, Takeda, Callisto Consultant: Novartis, Roche, Ipsen, Takeda, Genentech, Pfizer Laila Khazai Has no relevant financial relationships Howard McLeod Consultant: Bayer Speakers’ Bureau: Genentech Stock/Shareholder: Cancer Genetics, Inc., Interpares Biomedicine Louise Morrell Has no relevant financial relationships Zeina Nahleh Has no relevant financial relationships Amber Orman Has no relevant financial relationships Sofia Palacio Has no relevant financial relationships Luis Raez Grant/Research Support: BMS, Merck, AstraZeneca, Novartis, Roche, Syndax Jeremy Ramdial Has no relevant financial relationships Brittany Rogers Has no relevant financial relationships

1

FACULTY DISCLOSURE (onsite distribution)

Edgardo Santos Speakers’ Bureau: Genentech, AZ, BI, Merck, Amgen, Celgene, Takeda, Pfizer Aulakh Sonikpreet Has no relevant financial relationships Stephanie Valente Has no relevant financial relationships Tim Williams Has no relevant financial relationships Jinsong Zhang Grant/Research Support: AstraZeneca Consultant: AstraZeneca Speakers’ Bureau: Sanofi

Planning committee Ray Bailey Has no relevant financial relationships Seth Berkowitz Has no relevant financial relationships Amanda Brahim Has no relevant financial relationships Amanda Bridges Has no relevant financial relationships Delmarie Butler Has no relevant financial relationships Rosa Caiseda-Acantilado Has no relevant financial relationships Don Champlain Has no relevant financial relationships Melody Chang Has no relevant financial relationships Gail Erentreich Has no relevant financial relationships Ana Rosa Espinosa Has no relevant financial relationships Jorge Garcia Has no relevant financial relationships Addeshir Hakam Has no relevant financial relationships Cheryl Habaue Has no relevant financial relationships Eric Harris Consultant: AstraZeneca, Bristol Meyers Squibb, Novartis Speakers’ Bureau: Bristol Meyers Squibb, Amgen, Novartis Deborah Hawkins Has no relevant financial relationships Mohammed Jahnazeb Grant/Research Support: Lilly, Boehringer-Ingelheim, Takeda, Callisto Consultant: Novartis, Roche, Ipsen, Takeda, Genentech, Pfizer Mayra Lima Speakers’ Bureau: Genentech, Eisai, Myriad Shannon Luker Has no relevant financial relationships Richard McDonough Speakers’ Bureau: Rigel Other: Bayer Dina Dumercy McHenry Has no relevant financial relationships Anay Moscu Has no relevant financial relationships Zeina Nahleh Has no relevant financial relationships Julie Newberry Has no relevant financial relationships Dorothy Phillips Has no relevant financial relationships Brendan Prendergast Has no relevant financial relationships

2

FACULTY DISCLOSURE (onsite distribution)

Joseph Rosenblatt Grant/Research Support: Kite, Pharmacyclics Consultant: Merck, Mologen, Biograph55 Jose Sandoval-Sus Has no relevant financial relationships Edgardo Santos Speakers’ Bureau: Genentech, AZ, BI, Merck, Amgen, Celgene, Takeda, Pfizer Tan Winston Speakers’ Bureau: Genentech, AZ, BI, Merck, Amgen, Celgene, Takeda, Pfizer Beau Toskich Advisor: BIG, Boston Scientific, Johnson & Johnson Teri Valls Has no relevant financial relationships Adrienne Vazquez Guerra Has no relevant financial relationships Katrina Williams Has no relevant financial relationships Jonathan Zager Grant/Research Support: Amgen, Delcath, Provectus, Philogen, Novartis, Castle BioSciences Consultant: Castle BioSciences, Amgen, Philogen, Array, Sun Pharma Speakers’ Bureau: Amgen, Array, Sun Pharma

CME Reviewers Bina George-Figueroa Has no relevant financial relationships (JA provider) Edgardo S. Santos Speakers Bureau: Genentech, Lilly, Celgene, Millennium, Amgen, AstraZeneca, Merck, Boehringer Ingelheim Teri Valls Has no relevant financial relationships (JA provider)

Each speaker will directly disclose the use of products for which are not labeled (e.g., off label use) or if the product is still investigational.

ALL SPEAKERS HAVE BEEN REQUESTED TO VERBALLY DISCLOSE PRIOR TO THEIR PRESENTATION AND TO KEEP THEIR PRESENTATION UNBAISED AND GENERIC WHEN APPLICABLE.

3

SAVESAVE THETHE DATEDATE AprilApril 1111--13,13, 20192019

2019 FLASCO Spring Session with Business of Oncology Summit Gaylord Palms Resort & Convention Center 8701 World Center Dr. Orlando, FL 32821 For more information, please visit the FLASCO website at, WWW.FLASCO.ORG. SAVESAVE THETHE DATEDATE NovemberNovember 77--9,9, 20192019

2019 FLASCO Fall Session Renaissance Orlando at Sea World 6677 Sea Harbor Dr. Orlando, FL 32821

For more information, please visit the FLASCO website at, WWW.FLASCO.ORG. FLASCO: The Voice of Oncology in Florida Florida Society Of

Clinical Oncology

Jan 19, 2019 Cleveland Clinic Florida 2019 Best of San Antonio Breast Cancer Symposium, Marriott Harbor Beach Resort & Spa, Fort Lauderdale, FL

Jan 19, 2019 Moffitt Cancer Center Clinical Breakthroughs and Challenges in Hematologic Malignancies, Grand Floridian, Lake Buena Vista, FL

Feb 1-2, 2019 FLASCO Puerto Rico Oncology Symposium, La Concha, San Juan, PR

Feb 14-17, 2019 24th Annual Multidisciplinary Symposium on Breast Disease, Amelia Island, FL

Mar 8, 2019 Moffitt Cancer Center APP Current Concepts, Moffitt Cancer Center, Tampa, FL

Mar 29-31, 2019 Miami Cancer Meeting, Trump National Hotel– Doral, FL

Mar 30, 2019 LLS Blood Cancer Conference, Marriott Beach, Ft. Lauderdale, FL

Apr 11-13, 2019 FLASCO Spring Session & Business of Oncology Gaylord Palms, Kissimmee, FL

July 12-13, 2019 Memorial Hospital 2019 Best of ASCO

July 18-20, 2019 New Orleans Summer Cancer Meeting, New Orleans, LA

Oct 25-27, 2019 Florida Cancer Specialists Clinical Summit JW Orlando

Nov 7-9, 2019 2019 FLASCO Fall Session, Renaissance Orlando at Sea World

Apr 2-4, 2020 2020 FLASCO Spring Session with Business of Oncology Summit Gaylord Palms Resort & Convention Center

Oct 29-31, 2020 2020 FLASCO Fall Session, Gaylord Palms Resort

For more information, please contact: Dorothy Phillips, FLASCO Executive Director SAVE THE 10022 Water Works Lane, Riverview, FL 33578 Office: 813.677.0246 │ Fax: 813.677.0559 DATES! [email protected]

www.FLASCO.org FLASCO Fall Session November 9 &10, 2018

ROSTER OF ATTENDEES

Hina Abbas David Asher MD Karen Beauchamp Moffitt Cancer Center University of Miami BMS Tampa FL Miami, FL Lago Vista TX

Toni Abbasi Shannon Ashmon Laura Beck ARNP Varian Medical Systems Eisai, Inc Orlando Health Sugar Land TX Sarah Ashton Peter Benavente Simon Abi Aad MD Guardant Health Teva Florida Cancer Specialists Beverly Hills MI Naples FL Sonikpreet Aulakh MD Mayo Clinic Florida Patricia Benjamin Syed Abid MD, FACP Jacksonville, FL Tampa FL Pinellas Hematology & Oncology, PA St Petersburg, FL Steven Ayoub Ellen Bereznak Pfizer Biosimilars Eisai Peter Adeosun BSc, MS High Springs FL Boca Raton FL University of Florida College of Pharmacy - Orlando Nicholas Bacon PharmD, BCPS Seth Berkowitz Lake Mary FL Miami Cancer Institute-Baptist Health South The Leukeima and Lymopha Society Florida - Coral Gables Muhamad Alhaj Moustafa MD Miami FL Barry Berman MD Mayo Clinic Florida Broward Health Jacksonville FL Ray Bailey RPh Rx to Go Florida Cancer Specialists Tony Bernardini Ahmed Al-Hazzouri MD Ft. Myers, FL Boehringer Ingelheim Oncology Florida Cancer Specialists Candice Baldeo MD, MBBS Mayo Clinic Florida Monica Bertagnolli MD Muhamad Alohaj Moustafa MD Jacksonville FL Brigham and Women's Hospital, Dana Farber Mayo Clinic Florida Cancer Institute/Harvard Medical School Anthony Baldoni Boston, MA Carmen Alvarez Merck Incyte Jason Bever CORAL GABLES FL Christy Banach Helsinn Florida Cancer Specialists Valrico FL Nick Amendola Englewood FL Amgen Bob Bexley Rajesh Banderudrappagari MD Bill Amick HSHS Medical Group Amy Bignon Nanostring Springfield IL Lilly Oncology Sunny Isles Bch FL Candice Banks Bonita Billue Lisa Anderson Palm Bay, FL Hematology-Oncology Associates of the McKesson Treasure Coast Cindy Barnard Jenny Anson Roche Diagnostics Susan Binder Bristol Myers Squibb Brownsburg IN BriovaRx Wellington FL Merritt Island FL Kevin Barr Ollie Anum PharmD Daiichi Sankyo, Inc. Barbara Bittner RN, BSN,OCN Patient Advocacy Florida Hospital Brandon FL Nord Bathon Brett Blum Nanostring Florida Cancer Specialists & Research Institute Ollie Anum PharmD Fort Myers FL Imma Baylon BSN, RN Robert Armenia H. Lee Moffitt Cancer Center - Tampa Jordan Bolooki PharmD Astellas Largo FL University of Miami Sylvester Comprehensive

Cancer Center Mabel Arslanyan BS, PharmD, BCOP Ritche Baylon LPN Weston FL H. Lee Moffitt Cancer Center - Tampa David Asher MD Seminole FL Eric Borchers University of Miami McKesson Miami FL

(Current as of October 25, 2018) FLASCO Fall Session November 9 &10, 2018

ROSTER OF ATTENDEES

Amanda Brahim PharmD Jessica Busquets Melisa Chandler Memorial Healthcare System Cleveland Clinic Florida Florida Cancer Specialists Sunrise, FL Fort Myers FL Jessica Busquets Kayla Brice Cleveland Clinic Florida Melody Chang RPh, MBA, BCOP Nova Southeastern University Weston, FL Florida Cancer Specialists & Research Institute Plantation FL Delmarie Butler Monica Chatwal Lisa Briggs Moffit Cancer Center TESARO Chris Byrne Oncology Supply Chakra Chaulagain MD, FACP John Brockenshire Dothan AL Cleveland Clinic Bristol-Myers Squibb Weston, FL Delray Beach FL Rosa Caiseda, MSW Miami Cancer Institute Ruqin Chen MD, MS Lauren Brod Mayo Clinic Takeda Oncology Bethany Campbell Ponte Vedra Beach FL Surterra Bonnie Brogel Karina Chisholm Alexion Melissa Carmine Moffitt Cancer Center Daiichi Sankyo Lakeland FL Anita Brooks RN, BSN Broward Health Coral Springs Misha Carson Bridget Chiuchiolo Margate FL UF Health Cancer Center at Orlando Health Taiho Oncology Groveland FL Viera FL Eileen Brooks Astellas Kate Carter Perry Chohan WILMINGTON DE Alexion Astrazeneca

Janaee Brown Robert Cassell MD, PhD Michaela Christian-Simpson Florida Medical Clinic Retired University of Miami Sylvester Comprehensive Zephyrhills FL Winter Haven, FL Cancer Center Lauderdale Lakes FL William Brum Abby Castillo PUMA BIOTECHNOLOGY Memorial Healthcare System Patsy Clarke BSN Jacksonville FL Moffitt Cancer Center Julie Catherman Tampa FL Tim Bryant Agios Sanofi/ Genzyme Atlanta, GA Steve Cobb Seattle Genetics Mindy Bubar Lynda Cavener Janssen Biotech, Inc. Teva Pharmaceuticals Megan Coghlan St. Augustine FL Pensacola FL Total Health Conferencing Boca Raton FL Cheryl Buck Mary Cay Futo RN, CMR Walgreens Specialty Pharmacy Novartis Andres Colorado Oviedo FL Sanofi Genzyme Sarah Cevallos Miami FL Leah Burdett Florida Cancer Specialists Takeda Oncology Estero FL Patty Cooper AMAG Pharmaceuticals Jan Burger MD, PhD Sarah Cevallos MD Anderson Cancer Center/The University of Florida Cancer Specialists Erica Corcoran MSN, RN, OCN, AOCNS Texas Fort Myers, Fl Florida Hospital Cancer Institute - Orlando Houston, TX Orlando FL Don Champlain Nefertari Burrell Martha Cornatzer Quest Diagnostics Asher Chanan-Khan MBBS, MD Myriad Genetics Mayo Clinic Florida Scott Burtt Jacksonville, FL Katie Corso Genentech Bayer Trinity FL

(Current as of October 25, 2018) FLASCO Fall Session November 9 &10, 2018

ROSTER OF ATTENDEES

Denise Costolo John Diaz Cristina Duque Abbvie Novartis Florida Cancer Specialists & Research Institute Fort Myers FL Adrienne Crawford Mario Diaz Pfizer Biosimilars TEVA ONCOLOGY James Dwyer Braden River FL RxVantage Nicole Crawford El Segundo CA Novartis Michael Diaz MD Waxhaw NC Florida Cancer Specialists Ed Earnest St. Pete, FL Merck Paul Cruz Tampa FL Merck Saray Diaz-Garcia MSN, RN, NP-C, CMSRN Broward Health Medical Center Coral Springs Nikki Earnest RN, BSN Brandy Cunningham Coral Springs FL Novartis Cancer Care Centers of Brevard Tampa FL Palm Bay FL Ted Diehl IBM Watson Healthcare Matthew Earney PharmD Tim Curlee Florida Cancer Specialists TEVA Oncology Michael DiNatale Fort Myers FL Eisai Mark Curran Michael Eddy AMAG Pharmaceuticals Jennifer Dodge Adaptive Biotechnologies Merck Bradenton FL Vivian Curran Sanofi-Genzyme Dawn Dolan Christopher Edwards Palm Harbor FL Merck Lexicon Lutz FL Delray Beach FL Chad Davidson AstraZeneca Alyssa Donadio Kellie Edwards RN, OCN, CMSRN Jupiter FL Baptist Hospital of Miami Memorial Hospital West Pembroke Pines FL Beth Davison MSN, APRN, CNM Sandy Donaldson The Leukemia and Lymphoma Society MITRA BIOTECH INC Malena Egizio Rye Brook, NY Woburn MA Astellas North Palm Beach FL Elizabeth De Cosmo MSN, ARNP, AOCN-C Michelle Dones Florida Hospital Genentech BioOncology Longwood FL Coral Springs FL Alana Ellingham BTG International Ann DeCarr RN, OCN Serena Dragotta Florida Hospital Deland Florida Cancer Specialists & Research Institute - Cathy Elstner RN, BSN Deltona FL Venice Moffitt Cancer Center Fort Myers FL Tampa, FL Craig Deligdish MD Omni Healthcare Leylah Drusbosky Mems Emswiler Melbourne, FL NantHealth Foundation Medicine Gainesville FL Orlando FL Anna Dellarole University of Miami Dana Drzayich Antol Gail Erentreich MIAMI FL Representing Bristol Myers Squibb Cancer Care Centers of Brevard Rockledge, FL Heather DeRue-Biddle Evelyn Duenas-Silva IPSEN Biopharmaceuticals,Inc. Alexion Ana Rosa Espinosa DNP, MBA, RN, OCN Apollo Beach FL Memorial Cancer Institute Drew Dugger Hollywood, FL Jasreman Dhillon MD Rigel Moffitt Cancer Center Lake Mary FL Jimmy Evans Tampa, FL Seattle Genetics Shari Duncan Jacksonville FL Gloriana Diaz Florida Cancer Specialists & Research Institute - Array Bopharma Venice Mio Ezura Coral Gables FL Fort Myers FL Nova Southeastern University

(Current as of October 25, 2018) FLASCO Fall Session November 9 &10, 2018

ROSTER OF ATTENDEES

Dustin Faircloth Sarah Francis PharmD, BCOP Kathleen Gray PhD, BS ION Solutions Jackson Memorial Hospital Janssen-The Pharmaceutical Division of Dothan AL Miami, FL Johnson & Johnson Atlanta GA Matt Farber Laura Freedman MD Walgreens University of Miami Glen Greenwood Deerfield IL Deerfield Beach, FL Bristol-Myers Squibb Lebanon TN Benjamin Farnia MD Miles Furnish University of Miami Takeda Oncology Melodie Griffith Poindexter Miami, FL Katreen Gabriel Amgen UM-Sylvester Bilal Farooqi MD Adrienne Vazquez Guerra MSN, ACNP-BC, University of Florida Health - Gainesville Ana Garcia ApRN, MSN, FNP AOCNP Tampa FL Memorial Cancer Institute, Memorial Healthcare Sylvester Comprehensive Cancer Center, System University of Miami Natalie Feazell RN, BSN Pembroke Pines, FL Miami, FL Florida Hospital Memorial Medical Center Cancer Institute Jorge Garcia PharmD, MS, MHA, MBA, Martin Gutierrez MD Ormond Beach FL FACHE Miami, Cancer Institute, Baptist Health South Brad Gwirtz Steven Fein MD Florida Alexion Miami Cancer Institute Miami, FL Coral Gables, FL Cheryl Habaue MSN, RN, OCN, CCRP Faithlore Gardner MD Stuart Feinzig Florida Cancer Specialists Emily Hackett Novocure Cape Coral, FL MITRA BIOTECH INC Woburn MA Kevin Feldman Jason Gemeiner ION Solutions Verastem Oncology Rob Haefeli Dothan AL Alexion Karen Genzardi RN,OCN Karen Fields MD Florida Cancer Specialists & Research Institute - Ardeshir Hakam MD, MBA Moffitt Cancer Center- Tampa Inverness Moffitt Cancer Center Heather Filipkowski Inverness FL Tampa, FL Bristol-Myers Squibb Windermere FL Chanda George Dale Hansen Teva Oncology Sanofi Genzyme Karen Fitzgerald MBA Wellington FL Astellas Pharmaceutical Leeann Hanson Orlando FL David Geske Florida Cancer Specialists & Research Institute - Amgen Fort Myers FL Shaun Fitzmorris Alexion Raymond Gingrich Lorri Harrell AstraZeneca Quest Diagnostics Sergio Fleites Parrish FL Array Biopharma William Harrer MD Miami FL Len Giuliano Florida Cancer Specialists Seattle Genetics Crystal River, FL Alani Floyd Boca Raton FL Pharmacyclics Eric Harris DO Shelly Glenn Florida Cancer Specialists Corinne Floyd Florida Cancer Specialists Daytona Beach, FL Janssen Biotech, Inc. Sarasota, FL Miami FL Christin Hart RN, BSN, OCN Katie Goodman RN, BSN, CCRP Florida Hospital - Orlando Victoria Folan Florida Cancer Specialists Apopka FL Amgen Harish Gowda MBA Christin Hart RN, BSN, OCN Nicole Fortenbery Mid Florida Cancer Centers - Orange City Florida Hospital Cancer Institute Eli Lilly & Company Lake Mary FL Orlando, FL

(Current as of October 25, 2018) FLASCO Fall Session November 9 &10, 2018

ROSTER OF ATTENDEES

Deborah Hawkins, ARNP Karen Humphreys Jay Jolly Florida Cancer Specialists UF Health Cancer Center –Gainesville Bayer Maen Hussein MD Woodstock GA Donald Heinrich Florida Cancer Specialists Suncoast Cancer Institute - Sarasota Leesburg, FL Sophia Jones Sarasota FL Oncology Supply Todd Hutson Randal Henderson MD EMD Serono, Inc. Scott Jorgensen University of Florida Proton Therapy Incyte Jacksonville, FL Tara Hylton Florida Cancer Data System Brian Joy Kelly Hendricks Alexion TESARO Kankendria Ingram Merck Michelle Kaier Crystal Hendrix Lilly, USA Novartis Madiha Iqbal MD, MBBS Ponte vedra FL Stacy Heredia RN Mayo Clinic MHW JACKSONVILLE FL Sachin Kamath MD Florida Cancer Specialists Diana Hernandez PharmD Kirsten Ireson Miami Cancer Institute Eisai Oncology Pavan Kancharla MD Coral Gables FL Cancer Care Centers of Brevard Rubirosa Ison RN Palm Bay FL Andrew Hertler MD, FACP BayCare Health System Paula Karagounis RN New Century Health Lutz FL Moffitt Cancer Center Brea, CA Vincent Iuliani Land O Lakes FL Lisa Hickman Genentech Syneos Health Ellen Karp-Bendana Altamonte Springs FL Mohammad Jahanzeb MD, FACP, FASCO Bayer Oncology Sylvester Comprehensive Cancer Center, Miller Kathryn Keith John Hiemenz MD, FACP, FIDSA School of Medicine, University of Miami Merck University of Florida College of Medicine Deerfield Beach, FL Gainesville, FL Sean Kelley Dawn Javino Array Biopharma Brandon Hillenburg Merck Tampa FL Surterra Tampa FL Chris Kemp Aly Hirji Dominique Jean Baptiste RN Abbvie Pharmaceuticals TESARO Broward Health Coral Springs Medical Center Melbourne FL Margate FL Robin Kennedy Pfizer Amyn Hirji Denise Jeffrey Melbourne Beach FL Rigel Pharmaceuticals Nora Jensen Valrico FL Jazz Pharmaceuticals John Kerstiens MBA Cancer Care Centers of Brevard Charise Holcombe Angela Johnson Melbourne FL Genentech Caris Life Sciences Gainesville FL Julia Khalil PharmD, BCPS Daniel Johnson Sylvester Comprehensive Cancer Carley Hollis RN Pfizer Biosimilars Center,University of Miami Florida Medical Clinic Tampa FL Miami, FL Wesley Chapel FL Kimberly Johnson Waseem Khan MD Tony Honingford Heron Therapeutics Cancer Care of North Florida Genentech MARCO ISLAND FL Laila Khazai MD Michael Houser Shelli Johnson Moffitt Cancer Center Boehringer Ingelheim Oncology Cancer Care Centers of Brevard Tampa, FL

Donna Huffstater Tim Johnson Sharad Khurana MD Merck Helsinn Mayo Clinic Tampa FL Jacksonville FL

(Current as of October 25, 2018) FLASCO Fall Session November 9 &10, 2018

ROSTER OF ATTENDEES

Sean Kilker Christine Li Laura Martin RN Pfizer Inc Pfizer Orlando Health - UF Health Cancer Center Jacksonville FL St Petersburg FL Winter Garden FL

Julie King Judith Lightsey MD Leyner Martinez PharmD, MS Seattle Genetics Timber Ridge Medical Center - Robert Joe DiMaggio Children's Hospital - Memorial Melbourne FL Boissoneault Oncology Institute Healthcare System Ocala FL Miami Lakes FL Keylow King PharmD, MBA Verastem Oncology Mayra Lima ARNP, MSN, FNP-C Shahla Masood MD Brandon FL Sylvester Cancer Center University of Florida Plantation, FL Jacksonville, FL Kevin Kinsella Caris Life Sciences Jennifer Lucisano Richard Massaro Varian Medical Systems Teva Pharmaceuticals David Konicek Atlanta GA Tampa FL Merck Andrea Luker Josh Mattson Dennis Kotlove Quest Diagnostics Mayo Clinic Florida Richard Winter Cancer Center Adam Mauldin Manlius NY Shannon Luker BSN, OCN, CBCN, CN-BN McKesson Parrish Medical Center Barbara Kraemer Titusville, FL Scott McCullam RTR Florida Cancer Specialists & Research Institute - Pharmacyclics Venice Cheryl Luna RN Tallahassee FL Tampa FL Moffitt Cancer Center Erin McDonough ARNP K.S. Kumar MD, FACP Amy Macalintal Florida Medical Clinic Florida Cancer Specialists Foundation Medicine Richard McDonough MD Rich Lancellot Reshma Mahtani DO Florida Medical Clinic Boehringer ingelheim Oncology Sylvester Cancer Center Deerfield Beach, FL Kelly McFadden Annie-Claude Lapostolle MD Daiichi Sankyo AC Lapostolle INC Yan Makeyev MD Basking Ridge NJ St-Jean-sur-Richelieu QC 21st Century Oncology Orange Park, FL Dina Dumercy McHenry PharmD, BCOP, Kim Lauerman BCPS Heron Therapeutics Adrianne Mallen MD Miami Cancer Institute, Baptist Health South ALPHARETTA GA Moffitt Cancer Center Florida Pembroke Pines, FL Sharon Lavely Shank Manchepalli Florida Medical Clinic Verastem Oncology Howard McLeod PharmD Zephyrhills FL Stacy Manges Moffitt Cancer Center Taiho Oncology, Inc. Tampa, FL Dan Leber St. Augustine FL Celgene Jessica McMillan DNP, FNP, APRN-BC Windermere FL Denise Mariconda RN, BSN Mayo Clinic Florida Orlando Health Jacksonville, FL Kari Lee ORLANDO FL Adaptive Biotechnologies Tarek Mekhail MD, MSc, FRCSI, FRCSEd Alan Marks MD Cancer Institute of Florida Xiomara Lever A R Marks Consulting LLC Orlando, FL Astellas Jacksonville, FL Orange park FL Denise Meyer PharmD Josh Marks Bristol-Myers Squibb Gary Levin SCIO Management Solutions Naples FL Florida Cancer Data System Debra Marsala Julie Meyer ARNP Richard Levine MD Spectrum Novartis Oncology - Tampa Moffitt Cancer Center Naples FL Tampa FL Tampa, FL

(Current as of October 25, 2018) FLASCO Fall Session November 9 &10, 2018

ROSTER OF ATTENDEES

Joseph Mignone MD Deborah Nosotti ARNP Ricardo Parrondo MD 21st Century Oncology Orlando Health - UF Health Cancer Center Mayo Clinic Florida Orlando FL Jacksonville FL Jennifer Miller BHSF-MCI Judi Nunes Pareshkumar Patel MD Parkland FL Amgen Florida Cancer Specialists Tallahassee, FL Kena Miller Chris Nunnelee Takeda Oncology Gilead Sciences Daniel Patterson MD, PhD, MRCP BETHEL BLOOD AND CANCER CENTER, Eric Minor Ashley O'Connor PA Sandoz Flatiron Health Ocala FL

Leslie Mirani Chris Olney Entrinsic Health Solutions, Inc. Pfizer Biosimilars Kimberly Patton Norwood MA Bonita Springs FL Bristol-Myers Squibb (BMS) Mike Olson Bradenton FL Mehdi Moezi MD Novartis Cancer Specialists of North Florida Kenneth Peach MBA, BA Fleming Island, FL Amber Orman MD Health Council of East Central Florida Florida Hospital Medical Group/College of Winter Park FL Ashley Mohammed Medicine, University of Central Florida Merck Orlando, FL Katie Pell Amgen Jay Moore Jose Ortiz-Pagan Jennifer Peludat ARRT RT (R) (M) CBPN-1 Taiho Oncology Orlando, FL Halifax Health Medical Center Port Orange FL Louise Morrell MD Marcus Outzen Lynn Cancer Institute, Boca Raton Regional Guardant Health Olivier Peraud Hospital Pfizer Oncology Boca Raton, FL Stacy Paasche Tampa FL Florida Cancer Specialists Anay Moscu PharmD, BCPS, BCOP Fort Myers FL Lily Perez Moffitt Cancer Center Servier Tampa, FL Smitha Pabbathi MD Moffitt Cancer Center Heather Peterson Brian Motycka Tampa, FL Abbvie Pharmacyclics Mercy Padron Paul Petrillo Cynthia Muller RN BSN MJ Alexion Sandoz Bayer Oncology Palm Harbor FL Sofia Palacio MD Hung (Harry) Pham PharmD/MSBI Jackson Memorial Hospital/Miller School of Nova Southeastern University Zeina Nahleh MD, FACP Medicine, University of Miami Fort Lauderdale FL Cleveland Clinic Florida Miami, FL Weston, FL Evamarie Phan Giuseppe Palermo MD Surterra Hoyan Ng-Chen Cancer Care Centers of Brevard University of Miami Heath System/Sylvester Rockledge FL Sean Phelps Comprehensive Cancer Center Genentech Cooper City FL Jana Palmer Miramar FL Florida Cancer Specialists & Research Institute - Evania Nichols Venice Kathy Pickens Janssen Oncology - J&J Fort Myers FL Foundation Medicine Orlando FL Cynthia Paluch Marcos Pinho Daniel Nobel Taiho Oncology Caris Life Sciences University of Miami Palm Harbor FL Irving TX

Jennifer Nolin D'Iris Parrimon Brian Pipko Amgen University of Florida Astellas N PALM BEACH FL Palmetto FL Jupiter FL

(Current as of October 25, 2018) FLASCO Fall Session November 9 &10, 2018

ROSTER OF ATTENDEES

Herman Powery II PharmD Marcos Rejtman DO, HMDC Linda Ryan Memorial Regional Hospital Memorial Cancer Institute, Memorial Healthcare ME STRONG Hollywood, FL System DeLand FL Cooper City, FL Brendan Prendergast MD Anthony Rycerz Health First Cancer Institute Diana Reyes PharmD Sandoz Titusville, FL University of Miami Hialeah FL Shafique Saigol Don Prentiss Matt Ring Alexion

Amgen Alexion Amre Sammakia

Pfizer Oncology Justin Presutto PharmD, MBA Roxanne Rivas Daytona Beach FL Memorial Regional Cancer Institute Gilead Sciences

Boynton Beach FL Lutz FL Jose Sandoval-Sus MD

Moffitt Cancer Center Malignant Hematology & Louanne Provonsha Noraixa Rivera Cellular Therapy at Memorial Healthcare Novartis Incyte Corp System Powell TN Pembroke Pines, FL

Andria Roberts Bill Quarterman Florida Hospital Memorial Medical Center, Liz Santarsiero Sanofi Genzyme Cancer Institute Novartis Pharmaceuticals Fort Myers FL Deltona FL Davie FL

Ian Qureshi DO, PhD Lori Robinson Sandy Santiago RN Cancer Center at Larkin Astellas Moffitt Cancer Center Miami, FL Orlando FL Tampa FL

Luis Raez MD, FACP, FCCP Victoria Robinson PharmD, BCOP Edgardo Santos MD, FACP Memorial Cancer Institute, Memorial Healthcare Emory University Hospital Midtown Lynn Cancer Institute, Boca Raton Regional System/Florida International University Adel, Georgia Hospital/Florida Atlantic University Pembroke Pines, FL Boca Raton, FL Carol Rodriguez RN Jeremy Ramdial MD Memorial Hospital West Diana Saravia MD Jackson Memorial Hospital/Sylvester Pembroke Pines FL University of Miami Comprehensive Cancer Center, University of MIAMI FL Miami Health System Ines Rodriguez RN, OCN, CBCN Puma Biotechnology Tony Savine Brian Ramnaraign MD Pfizer University of Florida Melissa Rodriguez Palm City FL Gainesville, FL Merck Sharon Schall Megan Rask Roberto Rodriguez Seattle Genetics Pfizer Kite Pharma Boca Raton FL Davie FL Jessica Scheer RN Halifax Health Center for Oncology Lynn Rasys Brittany Rogers MD New Smyrna Beach FL Florida Cancer Specialists Foundation University of Florida Hematology/Oncology Sarasota FL Fellowship Program Debbie Schmitt Gainesville, FL Cancer Care Centers of Brevard Patty Rea Palm Bay FL Lilly Oncology Natalee Roper RN, BSN, CHPN Moffitt Cancer Center Jason Schwier Azure Reese Tampa, FL Celgene / Juno Exelixis Bixby OK Windermere FL Anita Roque Tempus Pauline Scott PharmD Mike Reese Orlando FL Miami Cancer Institute Verastem Oncology Miami FL Joseph Rosenblatt MD Anthony Register Sylvester Cancer Center David Segal Celgene Miami, FL Aetna Ocoee FL Tampa, FL

(Current as of October 25, 2018) FLASCO Fall Session November 9 &10, 2018

ROSTER OF ATTENDEES

Ellen Semans Amanda Stephens DO Rhonda Tompkins Kite, A Gilead Company Florida Hospital Orlando UF Health Cancer Center -Gainesville Tampa FL Lake Mary, FL Gainesville FL

Shalin Shah DO Jennifer Straussner Alfredo Torres MD Florida Cancer Specialists Florida Medical Clinic University of Miami/Jackson Memorial Hospital Tampa, FL Zephyrhills FL Miami FL

Jennifer Sibley Lee Stuart Beau Toskich MD Merck Mayo Clinic Florida Jennifer Sierra Jacksonville, FL Merck Jose Suarez Florida Hospital Lance Trainor Deepak Singh Deltona FL Alexion Seattle Genetics Tampa FL Beth Sussman YEN TRAN MBA Beth Sussman Consulting LLC Nova southeastern University Cheryl Smith Tampa, FL Davie FL Genentech Port Orange FL Dennis Sweeney Jeffrey Trocio Shire Glen Smith George Tucker Oncology Supply Liz Taffe Novartis Dothan AL Briova BRADENTON FL Marie-Eve Tucker PharmD Jacqueline Smith Broward Health Medical Center Coral Springs Bristol-Myers Squibb Katerina Tagaras PharmD Margate FL Lawrenceville NJ UM-Sylvester Miami FL Sara Turinsky Steven Smith BriovaRx Genentech Winston Tan MD Gainesville FL Mayo Clinic Florida Ed Twyford Jacksonville, FL Teva Pharmaceuticals Richard Smooke Winter Haven FL Quest Diagnostics Jill Tarrance AstraZeneca Dave Tyson Ileana Sosa Seattle Genetics Boehringer ingelheim Oncology Constance Terrell Memorial West Hospital Andrea Russell Uitti DNP, RN Curtis Sosnowski Davie FL Florida Center for Nursing & Florida Action Astellas Coalition Scott Tetreault MD Orlando, FL Carolina Soto Florida Cancer Specialists Alexion Mark Ulrich Jeff Tholen Teva Oncology Aixa Soyano Muller MD Agios Pharmaceuticals Bradenton FL Moffitt Cancer Center Gainesville FL Jacksonville FL Jessica Unzaga PharmD, BCPS, BCOP Juanita Thompson Miami Cancer Institute, Baptist Health South Richard Standifer Bayer Florida Bristol-Myers Squibb West Melbourne FL Miami Beach FL Danielle Usilton Pam Thoms Guardant Health Laura Stearns Merck Entrinsic Health Solutions, Inc. Tim Valencic Norwood MA Ken Tingley Seattle Genetics Pharmacyclics Jeff Steinberg Tampa FL Stephanie Valente DO, FACS Pfizer Cleveland Clinic Ohio NY NY Sierra Tomlinson Cleveland, OH Florida Cancer Specialists Fort Myers FL

(Current as of October 25, 2018) FLASCO Fall Session November 9 &10, 2018

ROSTER OF ATTENDEES

Teri Valls Andrea Warren-Smith Shawn Zaicek BSRT (R)(T) MECC Bristol-Myers Squibb Florida Hospital Miami, FL White GA Lake Mary FL

Bobby Van Atta Marjorie Weiner Eliott Zarett Incyte Corp. Retired Merck Destin FL Gainesville FL Sue Zellner James Van Kleunen Roy Weiner MD Surterra Pfizer Oncology Retired Miramar Beach FL Winter Springs FL Gainesville FL Eric Zetka Stephanie Van Winkle Joseph Whalen Amgen Surterra Guardant Health Inc MIAMI SHORES FL CUMBERLAND RI Elom Vanlare RN BSN Jingsong Zhang MD, PhD Moffitt Cancer Center Anita White RN Moffitt Cancer Center Tampa FL Florida Medical Clinic Tampa, FL Wesley Chapel FL Josean Vargas-Maisonet PharmD Bristol-Myers Squibb Jon Whiteside West Palm Beach FL Eisai

Vipul Vassa Maggie Wiegandt MBA Walgreens Specialty Pharmacy Memorial Healthcare System Orlando FL Hollywood, FL

Cathy Vasto Andrew Wilcox Exelixis Puma Biotech Jacksonville FL Bradenton FL Dave Williams Krystal Villasuso Merck Florida Cancer Specialists & Research Institute Viera FL Fort Myers FL Tim Williams MD Jo Visser South Florida Proton Therapy Institute Takeda Oncology Delray Beach, FL

Trinh Vu RN, BSN, OCN Laura Wineland Moffitt Cancer Center Celgene Tampa FL Tampa FL

Isabel Wagner Kimberly Winters Sandoz ME STRONG Princeton NJ DeLand FL

Charlotte Waldon Clayton Wright Foundation Medicine Takeda Oncology Naples FL Cai Yuan MD Alton Wallace University of Florida Gainesville Bayer Gainesville FL Royal Palm Beach FL Pam Yurcisin Shelley Walter Celgene ICU Medical, Inc Wesley Chapel FL San Clemente CA Katie Zacher MBA Resa Walters Florida Hospital Cancer Institute Roche Clermont FL Wesley Chapel FL

(Current as of October 25, 2018)

FLASCO was formed in 1977 as a statewide 501(c)(3) nonprofit organization committed to facilitating and promoting multidisciplinary efforts to improve patient care in Florida. FLASCO continues to make strides in promoting excellence in care of patients afflicted with cancer and hematologic disorders and leads efforts to respond to policies and legislation that threaten to compromise patient access to quality cancer care.

FLASCO is gaining momentum as more professionals use us as the catalyst to develop partnerships, share knowledge, and stand together to demonstrate strength and determination to move forward in the battle against cancer.

FLASCO consists of over 3,200 members that include physicians and their supporting staff, allied healthcare, and industry representatives that represent the oncology professionals of Florida.

FLASCO will continue to be recognized as a nationally respected state professional society as we stand together as “the Voice of Oncology in Florida”.